Umlobi: Clyde Lopez
Usuku Lokudalwa: 26 Ujulayi 2021
Ukuvuselela Usuku: 15 Unovemba 2024
Anonim
8 Excel tools everyone should be able to use
Ividiyo: 8 Excel tools everyone should be able to use

-Delile

Amagilebhisi izithelo zomvini. IVitis vinifera neVitis labrusca yizinhlobo ezimbili ezivamile zomvini. IVitis labrusca yaziwa kakhulu njengamagilebhisi weConcord. Zonke izithelo, isikhumba, amaqabunga kanye nembewu yesitshalo samagilebhisi kusetshenziswa njengomuthi. Imbewu yamagilebhisi iyimikhiqizo eyenziwe ngokukhiqizwa kwewayini. Qaphela ukuthi ungadidanisi amagilebhisi ne-grapefruit, neminye imithi efana nayo.

Amagilebhisi asetshenziselwa ukusabalalisa kahle okungadala ukuthi imilenze ivuvuke (ukungapheli kahle kwe-venous noma i-CVI) noma ukucindezela kwamehlo. Imikhiqizo yamagilebhisi ehlukahlukene nayo isetshenziselwa izifo zenhliziyo nemithambo yegazi, ezinye izinkinga zamehlo, impilo yamathumbu, nezinye izimo eziningi. Kepha abukho ubufakazi obuhle besayensi obusekela lokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze IBHOLA zimi kanje:


Kungenzeka kusebenze ...

  • Ukusakazeka okungalungile okungadala ukuthi imilenze ivuvukale (ukungapheli kahle kwe-venous noma i-CVI). Ukuthatha i-seed seed grape noma i-proanthocyanidin, ikhemikhali ezimbewini zamagilebhisi, ngomlomo kubonakala kunciphisa izimpawu ze-CVI ezinjengokukhathala noma imilenze esindayo, ukungezwani, nokushosholoza nobuhlungu. Ucwaningo luphakamisa ukuthi ukuthatha okukhishwayo kweqabunga lamagilebhisi ngomlomo kunciphisa ukuvuvukala kwemilenze ngemuva kwamaviki ayisithupha.
  • Ukucindezeleka kwamehlo. Ukuthatha imbewu yomvini ngomlomo kungasiza ekwehliseni ukucindezeleka emehlweni okuvela ekukhanyeni.

Kungenzeka kungasebenzi ku ...

  • Imfiva ethimulisayo. Ukuthatha imbewu yamagilebhisi kukhishwe amasonto ayi-8 ngaphambi kwenkathi ye-ragweed impova kubonakala kunganciphisi izimpawu zokungezwani komzimba zonyaka noma isidingo sokusebenzisa imishanguzo yokungezwani komzimba.
  • Ukucanuzela kwenhliziyo nokuhlanza okubangelwa ukwelashwa kwezidakamizwa zomdlavuza. Ukuthatha ama-ounces ama-4 wejusi yamagilebhisi weConstord obandayo imizuzu engama-30 ngaphambi kokudla isonto elilandelayo umjikelezo ngamunye we-chemotherapy akubonakali kwehlisa isicanucanu noma ukuhlanza okubangelwa ngamakhemikhali.
  • Izimpawu ezingezansi zomgudu womchamo (LUTS). Igama elithi LUTS livame ukusetshenziselwa ukuchaza izimpawu ezihambisana nesinye esisebenza ngokweqile. Ukuphuza ijusi yebanga le-Concord akubonakali kuthuthukisa lezi zimpawu emadodeni amadala.
  • Ubuhlungu besifuba (i-mastalgia). Ukuthatha iproanthocyanidin, ikhemikhali elitholakala ekukhipheni imbewu yamagilebhisi, kathathu nsuku zonke izinyanga eziyisithupha akubunciphisi ubunzima bezicubu zamabele, ubuhlungu, noma isisa kubantu abaphathwa ngemithi yokwelapha ngemisebe yomdlavuza webele.
  • Ukukhuluphala ngokweqile. Ukuphuza ijusi lamagilebhisi weConcord noma ukuthatha imbewu yamagilebhisi noma i-pomace yamagilebhisi akubonakali kwehlisa isisindo kubantu abakhuluphele ngokweqile. Kodwa-ke, kungasiza ukwehlisa i-cholesterol ekulawuleni ushukela wegazi.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Isikhumba esiguga. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha umkhiqizo othile ohlanganisiwe oqukethe ukukhishwa kwesikhumba samagilebhisi, ama-marine collagen peptides, i-coenzyme Q10, i-luteolin, ne-selenium izinyanga ezimbili kungahle kuthuthukise ezinye izimpawu zesikhumba esigugayo njengokuqina. Kodwa akubonakali kuthuthukisa umswakama wesikhumba noma ukuthi isikhumba sivela kanjani ngokuya ngeminyaka.
  • Ukuqina kwemithambo yegazi (i-atherosclerosis). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha umkhiqizo othize oqukethe uwoyela wembewu yamagilebhisi, ugarlic, uhobhose, itiye eliluhlaza, kanye nama-antioxidants unyaka owodwa kungasiza ekuvikeleni izingcwecwe ze-cholesterol ekwakhekeni kwemithambo yegazi. Kodwa akubonakali kuvimbela ukukhula kwamapuleti asevele ekhona emithanjeni yegazi. Futhi akubonakali kuthuthukisa amazinga we-cholesterol.
  • Ukusebenza kwezemidlalo. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha u-400 mg wamagilebhisi okhishwa nsuku zonke inyanga eyodwa kungakhuphula amandla omsubathi jikelele lapho egxuma, kepha hhayi amandla okuqala noma ukugcina amandla. Olunye ucwaningo lwakuqala lukhombisa ukuthi ijusi yokuphuza elungiselelwe kusuka kumgubo wamagilebhisi ophelele ayikuthuthukisi ukuthi umzimba uwusebenzisa kahle kanjani umoya-mpilo noma ikhono lokusebenza.
  • I-eczema (i-atopic dermatitis). Ucwaningo lokuqala lubonisa ukuthi ukufaka ukhilimu oqukethe uvithamini E namakhemikhali atholakala kumagilebhisi netiye eliluhlaza akuzinciphisi izimpawu ze-eczema.
  • Isifo senhliziyo. Kunobunye ubufakazi bakuqala bokuthi ukuphuza ijusi lamagilebhisi noma iwayini elibomvu kunganciphisa izinto ezinobungozi ezixhunyaniswe nesifo senhliziyo, njengokuvuvukala, ukwakheka kwamahlwili, nokonakala kwe-oxidative emafutheni egazi. Kodwa akwaziwa ukuthi imikhiqizo yamagilebhisi inciphisa ngqo ingozi yesifo senhliziyo.
  • Amakhono wokukhumbula nokucabanga (umsebenzi wokuqonda). Ucwaningo lwakuqala lukhombisa ukuthi ukuphuza ijusi lamagilebhisi eConcord kusiza abesifazane abaneminyaka ephakathi ukugxila ngenkathi beshayela. Futhi ukuthatha isithelo sesithelo samagilebhisi amasonto ayi-12 kubonakala kuthuthukisa ukunakwa, ulimi, nenkumbulo kubantu asebekhulile ngaphandle kwezinkinga zememori ehlobene nobudala. Akucaci ukuthi ngabe amagilebhisi athuthukisa ukusebenza kwengqondo noma inkumbulo kubantu asebekhulile abanezinkinga zememori ehlobene nobudala.
  • Nciphisa amakhono okukhumbula nawokucabanga kubantu asebekhulile okungaphezu kokujwayelekile ngeminyaka yabo. Ucwaningo oluningi lwakuqala luphakamisa ukuthi umvini awuthuthukisi ukusebenza kwengqondo noma inkumbulo kubantu asebekhulile abanezinkinga zememori.
  • Umdlavuza wamakholoni, umdlavuza we-rectal. Ukuthatha umkhiqizo oqukethe ukukhishwa kwembewu yamagilebhisi nezinye izithako ngenkathi uphathwa ngemithi yomdlavuza kubonakala kusiza ukuvimbela umdlavuza wekoloni nowesikhumba ekuqhubekeni. Kodwa akubonakali kuthuthukisa ukusinda.
  • Izinkinga zombono kubantu abanesifo sikashukela (i-retinopathy yesifo sikashukela). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha imikhiqizo ethize ekhipha imbewu yamagilebhisi kunganciphisa ukukhula komonakalo wamehlo obangelwa yisifo sikashukela.
  • I-cholesterol ephezulu. Ukuthatha imbewu yamagilebhisi noma ukukhipha amagilebhisi kunganciphisa ezinye izinyathelo ze-cholesterol namafutha egazi abizwa nge-triglycerides ngenani elincane kubantu abane-cholesterol ephezulu. Kubonakala sengathi ayithuthukisi i-high-density lipoprotein (HDL noma "okuhle") cholesterol. Kepha ezinye izifundo azivumelani, futhi akucaci ukuthi yimuphi umkhiqizo noma umthamo ongasebenza kahle kakhulu.
  • Umfutho wegazi ophezulu. Ucwaningo oluningi luhlolisise ukukhishwa kwembewu yamagilebhisi noma amakhemikhali ahlukanisiwe avela kumagilebhisi abizwa ngama-polyphenols kubantu abane-high blood pressure. Ucwaningo olulodwa lubonisa imiphumela ephikisanayo. Kepha ukuhlaziywa kwezifundo eziningi kusikisela ukuthi ukukhipha imbewu yamagilebhisi noma ama-polyphenols wamagilebhisi kunganciphisa kancane umfutho wegazi kubantu abaphilile noma kulabo abane-high blood pressure. Kubonakala sengathi zisebenza kahle kakhulu kubantu abakhuluphele noma abanesifo se-metabolic syndrome. Kungathatha amasonto ayisishiyagalombili ukuthi izinzuzo zibonakale.
  • Amabala wesikhumba amnyama ebusweni (i-melasma). Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha imbewu yamagilebhisi kukhishwe ngomlomo izinyanga eziyi-6-11 kunciphisa ukuguqulwa kwesikhumba esimnyama kwabesifazane baseJapan.
  • Izimpawu zokunqamuka kokuya esikhathini. Ukuthatha imbewu yamagilebhisi kukhishwa nsuku zonke amasonto ayi-8 kubonakala kunciphisa ukushisa okukhulu, ukukhathazeka, nezinye izimpawu zomzimba zokunqamuka kokuya esikhathini. Kungabuye kuthuthukise ubukhulu bomzimba obuncane kanye ne-diastolic blood pressure (inombolo engezansi ekufundeni kwengcindezi yegazi). Kodwa ukukhishwa kwembewu yamagilebhisi kubonakala kungathuthukisi ukuqwasha noma ukudangala.
  • Ukuqoqwa kwezimpawu ezandisa ubungozi besifo sikashukela, isifo senhliziyo, nesifo sohlangothi (isifo se-metabolic syndrome). Olunye ucwaningo lukhombisa ukuthi ukuthatha imikhiqizo yamagilebhisi kungasiza ekwehliseni umfutho wegazi kanye namazinga wamafutha egazi njenge-cholesterol kubantu abadala abane-metabolic syndrome. Kepha akwaziwa ukuthi lezi zinguquko zinciphisa ubungozi besifo sikashukela noma ezinye izici zesifo se-metabolic syndrome.
  • Ukopha okuncane. I-episiotomy ukusika okuhlinzwa okusetshenziselwa ukukhulisa ukuvulwa kwesitho sangasese sowesifazane ukusiza ekubelethweni. Ucwaningo lwakuqala lukhombisa ukuthi ukusebenzisa umkhiqizo obizwa nge-Ankaferd blood stopper, oqukethe i-alpinia, licorice, thyme, stinging nettle, nomvini wamagilebhisi kusiza ukunciphisa ukopha ngesikhathi sokulungiswa kwe-episiotomy. Kodwa akusinciphisi isikhathi sokuhlinzwa.
  • Ubuhlungu bemisipha. Ucwaningo lokuqala lukhombisa ukuthi ijusi yokuphuza elungiselelwe kusuka kumvini wamagilebhisi amasonto ayisithupha ngaphambi kokuhlolwa kokuzivocavoca kwengalo akubunciphisi ubuhlungu noma ukuvuvukala usuku olulodwa noma ezimbili ngemuva kokuzivocavoca.
  • Amandla okubona ezimweni zokukhanya okuphansi. Ucwaningo lwakuqala luphakamisa ukuthi ukukhishwa kwembewu yamagilebhisi equkethe amakhemikhali abizwa nge- proanthocyanidins kungahle kuthuthukise umbono wasebusuku.
  • Yakha amafutha esibindini kubantu abaphuza utshwala obuncane noma abangaphuzi (isifo sesibindi esinamafutha noma i-NAFLD). Ucwaningo lukhombisa ukuthi ukuthatha imbewu yamagilebhisi kukhishwa izinyanga ezintathu kuthuthukisa ukuhlolwa kwegazi kokulimala kwesibindi kubantu abanezifo zesibindi ezinamafutha ezingekho utshwala.
  • I-Premenstrual syndrome (i-PMS). Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha umkhiqizo othize wembewu yamagilebhisi kunganciphisa izimpawu ze-PMS, kufaka phakathi ubuhlungu nokuvuvukala.
  • Ukuphulukiswa kwesilonda. Ucwaningo lwakuqala lukhombisa ukuthi ukufaka ukhilimu oqukethe u-2% wokukhishwa kwembewu yamagilebhisi kunciphisa isikhathi sokuphulukiswa kwesilonda ngemuva kokususwa kwezilonda zesikhumba. Ucwaningo lwakuqala lukhombisa nokuthi ukufaka umuthi oqukethe u-5% wokukhishwa kwembewu yamagilebhisi kubonakala kusiza ekwelapheni isilonda kwabesifazane abathola ukwelashwa okulethwa yisigaba se-C.
  • Ukonakala kwe-macular okuhlobene nobudala (AMD).
  • Ukunakwa kokushoda-i-hyperactivity disorder (ADHD).
  • Izilonda zekhankatha.
  • Isifo sokukhathala okungamahlalakhona (CFS).
  • Ukuqunjelwa.
  • Khwehlela.
  • Uhudo.
  • Izinkathi ezinzima zokuya esikhathini.
  • Ama-hemorrhoids.
  • Ukulimala kwesibindi.
  • Ukwelapha imithambo ye-varicose.
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala ukusebenza kwamagilebhisi kulokhu kusetshenziswa.

Amagilebhisi aqukethe ama-flavonoid, angaba nemiphumela yokulwa ne-antioxidant, ehlise amazinga we-low density lipoproteins (LDLs, noma "cholesterol embi"), phumuza imithambo yegazi, futhi wehlise ubungozi besifo senhliziyo. Ama-antioxidants asemagilebhini angasiza ekuvikeleni isifo senhliziyo futhi abe neminye imiphumela engaba yinzuzo. Izinhlobo zamagilebhisi abomvu zinikeza ama-antioxidants amaningi kunezinhlobo zamagilebhisi ezimhlophe noma ezimhlophe.

Iqabunga lamagilebhisi linganciphisa ukuvuvukala futhi libe nemiphumela emibi. Ngamanye amagama, iqabunga lamagilebhisi libonakala likwazi ukudweba izicubu ndawonye, ​​ezingasiza ekunqandeni ukopha nohudo. Lezi zakhiwo zibonakala zikhulu kakhulu emaqabunga abomvu.

Lapho ithathwa ngomlomo: Amagilebhisi CISHE UVIKILE lapho kudliwe ngamanani atholakala kakhulu ekudleni. Kepha khumbula ukuthi, ngenxa yobukhulu nokuma kwayo, amagilebhisi aphelele angaba yingozi engalimaza izingane ezineminyaka engu-5 nangaphansi. Ukwehlisa ubungozi, amagilebhisi aphelele kufanele anqunywe phakathi noma ahlukaniswe kathathu ngaphambi kokuba anikezwe izingane.

Amagilebhisi OKUNGENZEKA UKUPHEPHA lapho ithathwa ngomlomo ngamanani okwelapha. Ukukhishwa kwembewu yamagilebhisi kanye nezithelo zezithelo zomvini kusetshenziswe ngokuphepha ezifundweni kuze kube izinyanga eziyi-12. Ukukhishwa kweqabunga lamagilebhisi kusetshenziswe ngokuphepha ezifundweni kuze kube amasonto ayi-12. Ukudla inqwaba yamagilebhisi, amagilebhisi omisiwe, omisiwe noma ama-sultana kungadala isifo sohudo. Abanye abantu banokungazwani komzimba kumagilebhisi nakwimikhiqizo yamagilebhisi. Eminye imiphumela emibi engaba khona ibandakanya ukucasuka kwesisu, ukugaya ukudla, isicanucanu, ukuhlanza, ukukhwehlela, umlomo owomile, umphimbo obuhlungu, ukutheleleka, ikhanda, nezinkinga zemisipha.

Lapho isetshenziswa esikhunjeni: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi ngabe umvini uphephile noma yini imiphumela emibi engaba khona.

Lapho isetshenziswa esithweni sangasese: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi ngabe umvini uphephile noma yini imiphumela emibi engaba khona.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele olunokwethenjelwa lokwazi ukuthi ngabe umvini uphephile yini ukusetshenziswa kumanani okwelapha lapho ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusebenzisa okungaphezulu kwemali engaphezulu etholakala ekudleni.

Izimo zokopha: Amagilebhisi angahle anciphise ukujiya kwegazi. Ukuthatha amagilebhisi kungakhuphula amathuba okulimala nokopha kubantu abanezimo zokopha. Kodwa-ke, ayikho imibiko yalokhu eyenzeka kubantu.

Ukuhlinzwa: Amagilebhisi angahle anciphise ukujiya kwegazi. Kungadala ukopha okwengeziwe ngesikhathi nangemva kokuhlinzwa. Yeka ukusebenzisa inani lomuthi wamagilebhisi okungenani amasonto ama-2 ngaphambi kokuhlinzwa okuhleliwe.

Maphakathi
Qaphela ngale nhlanganisela.
ICyclosporine (Neoral, Sandimmune)
Ukuphuza ujusi wamagilebhisi onsomi kanye ne-cyclosporine (i-Neoral, iSandimmune, i-Restasis, i-Gengraf) kunganciphisa ukuthi umzimba umunca malini i-cyclosporine. Lokhu kunganciphisa ukusebenza kwe-cyclosporine. Imithamo ehlukanisiwe yejusi yamagilebhisi ne-cyclosporine okungenani amahora ama-2 ukugwema lokhu kuhlangana.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 1A2 (CYP1A2))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ijusi lamagilebhisi lingakhuphula ukuthi isibindi sehlisa kanjani imithi ngokushesha. Ukuthatha amagilebhisi kanye neminye imithi eshintshwa yisibindi kunganciphisa ukusebenza kwale mithi. Ngaphambi kokuthatha amagilebhisi, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye yale mithi eshintshwa yisibindi ihlanganisa i-amitriptyline (Elavil), i-caffeine, i-chlordiazepoxide (i-Librium), i-clomipramine (i-Anafranil), i-clopidogrel (i-Plavix), i-clozapine (i-Clozaril), i-cyclobenzaprine (i-Flexaril), i-desipramine (i-Norpramin) Valium), estradiol (Estrace, abanye), flutamide (Eulexin), fluvoxamine (Luvox), grepafloxacin (Raxar), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), mirtazapine (Remeron), naproxen i-nortriptyline (Pamelor), i-olanzapine (i-Zyprexa), i-ondansetron (i-Zofran), i-propafenone (i-Rythmol), i-propranolol (i-Inderal), i-riluzole (i-Rilutek), i-ropinirole (i-Requip), i-ropivacaine (i-Naropin), i-tacrine-Cognex (i-Cognex), , abanye), verapamil (Calan, Covera-HS, others), warfarin (Coumadin), kanye zileuton (Zyflo).
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2D6 (CYP2D6))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ukukhishwa kwembewu yamagilebhisi kungahle kunciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha imbewu yomvini kanye neminye imithi eguqulwa yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yale mithi. Ngaphambi kokuthatha okukhishwe imbewu yamagilebhisi, khuluma nomhlinzeki wakho wezokunakekelwa kwezempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye yale mithi eshintshwa yisibindi ihlanganisa i-amitriptyline (Elavil), i-clozapine (i-Clozaril), i-codeine, i-desipramine (i-Norpramin), i-donepezil (i-Aricept), i-fentanyl (i-Duragesic), i-flecainide (i-Tambocor), i-fluoxetine (i-Prozac), i-meperidine ( Demerol), methadone (Dolophine), metoprolol (Lopressor, Toprol XL), olanzapine (Zyprexa), ondansetron (Zofran), tramadol (Ultram), trazodone (Desyrel), nabanye.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2E1 (CYP2E1))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ukukhishwa kwembewu yamagilebhisi kungahle kunciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha imbewu yomvini kanye neminye imithi eguqulwa yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yale mithi. Ngaphambi kokuthatha okukhishwe imbewu yamagilebhisi, khuluma nomhlinzeki wakho wezokunakekelwa kwezempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye yale mithi eshintshwa yisibindi ihlanganisa i-enflurane (i-Ethrane), i-halothane (i-Fluothane), i-isoflurane (i-Forane), i-methoxyflurane (i-Penthrane).
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 3A4 (CYP3A4))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ukukhishwa kwembewu yamagilebhisi kungahle kunciphise ukuthi isibindi sehla kanjani ngokushesha eminye imithi. Ukuthatha imbewu yomvini kanye neminye imishanguzo eguqulwa yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yale mithi. Ngaphambi kokuthatha okukhishwe imbewu yamagilebhisi, khuluma nomhlinzeki wakho wezokunakekelwa kwezempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye yale mithi eshintshwa yisibindi ifaka i-lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), neminye eminingi.
Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)
Amagilebhisi angahle anciphise ukujiya kwegazi. Ukuthatha amagilebhisi kanye nemithi futhi ejija kancane ukuvimba kungandisa amathuba okulinyazwa nokopha.

Eminye imithi eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox), i-heparin, i-indomethacin (i-Indocin), i-ticlopidine (i-Ticlid), i-warfarin (i-Coumadin), neminye.
I-Midazolam (Inamavesi)
Ukuthatha okukhishwe imbewu yamagilebhisi okungenani isonto elilodwa kungakhuphula ukuthi umzimba ususa kanjani ngokushesha i-midazolam (Versed) efakwe emithanjeni. Lokhu kunganciphisa ukusebenza kahle kwe-midazolam (Versed). Ukuthatha umthamo owodwa kuphela wokukhishwa kwembewu yamagilebhisi kubonakala kungathinti ukuthi umzimba ususa ngokushesha kangakanani i-midazolam (Versed).
I-Phenacetin
Umzimba wephula i-phenacetin ukuze uyiqede. Ukuphuza ijusi lamagilebhisi kungakhuphula ukuthi umzimba wephula kanjani i-phenacetin ngokushesha. Ukuthatha i-phenacetin kanye nejusi lamagilebhisi kunganciphisa ukusebenza kwe-phenacetin.
I-Warfarin (Coumadin)
I-Warfarin (i-Coumadin) isetshenziselwa ukunciphisa ukubamba kwegazi. Amafutha embewu yamagilebhisi nawo angahle anciphise ukuvimba kwegazi. Ukuthatha uwoyela wembewu yamagilebhisi kanye ne-warfarin (Coumadin) kungakhuphula amathuba okulimala nokopha. Qiniseka ukuthi uhlolwa igazi lakho njalo. Umthamo we-warfarin yakho (i-Coumadin) ungadinga ukuguqulwa.
Okuncane
Qaphela ngale nhlanganisela.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C9 (CYP2C9))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. Ijusi lamagilebhisi noma ukukhishwa kwembewu yamagilebhisi kungahle kunciphise ukuthi isibindi sephula kanjani imithi ethile ngokushesha. Ukuthatha amagilebhisi kanye neminye imishanguzo eguqulwa yisibindi kungakhuphula imiphumela kanye nemiphumela emibi yale mithi. Ngaphambi kokuthatha amagilebhisi, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo uma uthatha noma yimiphi imithi eshintshwa yisibindi.

Eminye yale mithi eshintshwa yisibindi ifaka i-amitriptyline (Elavil), diazepam (Valium), zileuton (Zyflo), celecoxib (Celebrex), diclofenac (Voltaren), fluvastatin (Lescol), glipizide (Glucotrol), ibuprofen (Advil, Motrin), irbesartan (Avapro), losartan (Cozaar), phenytoin (Dilantin), piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), warfarin (Coumadin), nabanye.
I-Lactobacillus acidophilus
Amagilebhisi angahle anciphise noma amise ukukhula kweLactobacillus acidophilus emgodleni wamathumbu futhi asule imiphumela yawo. Ungathathi amagilebhisi ne-lactobacillus ngasikhathi sinye.
Uvithamini C
Ucwaningo lwakuqala luphakamisa ukuthi abantu abanengcindezi ephezulu yegazi abathatha bobabili uvithamini C 500 mg / ngosuku kanye namagilebhisi embewu yamagilebhisi i-1000 mg / ngosuku bakhuphule kakhulu umfutho wegazi. Ukwanda kubonakala kuzo zombili izinombolo eziphezulu (systolic) nezingezansi (diastolic). Abaphenyi abazi okwamanje ukuthi kungani lokhu kwenzeka.
Akukho ukuxhumana okwaziwayo nokudla.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

ABADALA
NGOMLOMO:
  • Ukusakazwa okungalungile okungadala ukuthi imilenze ivuvuke (ukungapheli kahle kwe-venous noma i-CVI):
    • Isicucu somvini obomvu esimisiwe sazi njengo-AS 195 360 mg noma u-720 mg kanye ngosuku amasonto ayisithupha kuya kwayi-12 sisetshenzisiwe.
    • Kusetshenzisiwe nokukhishwa kwembewu yamagilebhisi ethile equkethe i-proanthocyanidin 150-300 mg nsuku zonke inyanga eyodwa. Iproanthocyanidin ingesinye sezithako ezisebenzayo kumagilebhisi.
  • Ngokucindezeleka kwamehlo:
    • Kusetshenziswe okukhishwe imbewu ethile yamagilebhisi equkethe i-proanthocyanidin 200 mg nsuku zonke amaviki ama-5.
    • Kusetshenzisiwe ukukhipha imbewu yamagilebhisi i-proanthocyanidin ngomthamo wama-300 mg ngosuku.
    I-Activin, Amagilebhisi Amnyama Amagilebhisi, iCalzin, iDraksha, i-Enocianina, i-European Wine Grape, i-Extrait de Feuille de Raisin, i-Extrait de Feuille de Vigne Rouge, i-Extrait de Peau de Raisin, i-Extrait de Pepins de Raisin, i-Feuille de Raisin, i-Feuille de Vigne Rouge, I-Feuille de Vigne Rouge AS 195, i-Flame Grape, i-Flame Raisins, i-Flame Seedless, i-Folia Vitis Viniferae, i-Fox Grape, i-Grape Fruit, i-Grape Fruit Skin, iJusi lamagilebhisi, i-Grape Leaf, i-Grape Leaf Extract, i-Grape Polyphenols, i-Grom Pomace, iMvini yamagilebhisi Imbewu Yokukhipha, Amafutha Wembewu Yamagilebhisi, Isikhumba Samagilebhisi, Amagilebhisi Esikhumba, Amagilebhisi, Aqoshiwe, Huile de Pépins de Raisin, Kali Draksha, Leucoanthocyanin, Muscat, Muskat, Oligomères Procyanidoliques, Oligomeric Proanthocyanidins, Oligomeric Procyanidins, OPC, Peau de Raisin, Pépin de Raisin, Petite Sirah, Proanthocyanidines Oligomériques, Proanthodyn, Proanthodyne, Procyanidines Oligomériques, Procyanidolic Oligomers, Purple Grape, Raisin, Raisin Blanc, Raisin de Table, Raisin de Vigne, Raisins No d Globe, Red Grape, Red Malaga, Red Vine, Red Vine Leaf AS 195, Red Vine Leaf Extract, Skunk Grape, Sultanas, Table Grapes, Thompson Seedless, Uva, Vitis labrusca, Vitis vinifera, White Grape, Wine Grape, Iwayini lamagilebhisi .

    Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


    1. UGhaedi E, Moradi S, Aslani Z, Kord-Varkaneh H, Miraghajani M, Mohammadi H. Imiphumela yemikhiqizo yamagilebhisi kuma-lipids egazi: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta-response meta-analysis yezilingo ezilawulwa ngokungahleliwe. Umsebenzi Wokudla. 2019; 10: 6399-6416. Buka okungaqondakali.
    2. Izadpanah A, Soorgi S, Geraminejad N, Hosseini M. Umphumela wembewu yamagilebhisi ukhipha umuthi ekwelapheni kwesilonda se-cearean: isilingo somtholampilo esiyimpumputhe, esingahleliwe, nesilawulwayo. Qedela iTher Clin Pract 2019; 35: 323-8. Buka okungaqondakali.
    3. Inyanga SW, Shin YU, Cho H, Bae SH, Kim HK; kanye ne-Mogen Study Group. Umphumela wembewu yamagilebhisi i-proanthocyanidin ekhishwa kuma-exudates anzima ezigulini ezinesifo sikashukela esingabhebhetheki. Imithi (iBaltimore) 2019; 98: e15515. Buka okungaqondakali.
    4. UMartínez-Maqueda D, Zapatera B, Gallego-Narbón A, MP weVaquero, uSaura-Calixto F, uPérez-Jiménez J. Isengezo samasonto ayisithupha ngesivinini somvini ezifundweni ezisengozini ye-cardiometabolic senza ukuzwela kwe-insulin, ngaphandle kokuthinta ezinye izimpawu zesifo se-metabolic. Umsebenzi Wokudla.I-2018; 9: 6010-6019. Buka okungaqondakali.
    5. U-Urquiaga I, uTroncoso D, uMackenna MJ, et al. Ukusetshenziswa kwama-burger enkomo okulungiselelwe ngofulawa wamagilebhisi we-pomace kuthuthukisa i-glucose yokuzila, amazinga e-plasma antioxidant, nezimpawu zokulimala kwe-oxidative ebantwini: Isivivinyo esilawulwayo. Izakhamzimba. 2018; 10. pii: E1388. Buka okungaqondakali.
    6. UDe Luca C, uMikhal’chik EV, uSuprun MV, et al. Ukuncishiswa kwesikhumba kanye nemiphumela ye-redox yemiphumela yokwengeza ngama-marine collagen peptides nama-antioxidants atholakala ezitshalweni: isifundo semitholampilo esilawula icala elilodwa. I-Oxid Med Cell Longev. 2016; 2016: 4389410. Buka okungaqondakali.
    7. IMyasoedova VA, iKirichenko TV, iMelnichenko AA, et al. Imiphumela ye-anti-atherosclerotic yokulungiselela amakhambi acebile e-phytoestrogen kwabesifazane be-postmenopausal. Int J Mol Sci. 2016; 17. Buka okungaqondakali.
    8. UZu XY, Zhang ZY, Zhang XW, Yoshioka M, Yang YN, Li J. Anthocyanins akhishwe ku-blueberry waseChina (i-Vaccinium uliginosum L.) nemiphumela yawo yokulwa nomdlavuza kumaseli we-DLD-1 ne-COLO205. UChin Med J (Engl). 2010; 123: 2714-9. Buka okungaqondakali.
    9. UBerry AC, Nakshabendi R, Abidali H, et al. Imiphumela emibi yesengezo sokukhishwa kwembewu yamagilebhisi: Icala lomtholampilo nokulandelwa kwesikhathi eside. J Ukudla Suppl. 2016; 13: 232-5. Buka okungaqondakali.
    10. UHan HJ, uJung UJ, uKim HJ, et al. Ukwengeza okuhlanganisiwe ne-pomace yamagilebhisi kanye ne-omija izithelo ze-ethanol ezikhishwe ngomthamo-kuthuthukisa ukwakheka komzimba, amaphrofayli e-plasma lipid, isimo sokuvuvukala, namandla we-antioxidant ezifundweni ezikhuluphele ngokweqile. J Med Ukudla. 2016; 19: 170-80. Buka okungaqondakali.
    11. U-Lee J, uTorosyan N, uSilverman DH. Ukuhlola umthelela wokusetshenziswa kwamagilebhisi ku-metabolism yengqondo nokusebenza kwengqondo ezigulini ezinokwehla okuncane kokuqonda: Isifundo somshayeli we-placebo esilawulwa ngamehlo. Exp Gerontol. 2017; 87 (Pt A): 121-128. Buka okungaqondakali.
    12. UCalapai G, uBonina F, uBonina A, et al. Isivivinyo somtholampilo esingahleliwe, esimpumputhe kabili, emiphumeleni ye-Vitis vinifera ekhishwe ekusebenzeni kwengqondo kubantu abadala asebekhulile. Ngaphambili Pharmacol. 2017; 8: 776. Buka okungaqondakali.
    13. IPark E, Edirisinghe I, Choy YY, Waterhouse A, Burton-Freeman B. Imiphumela yembewu yamagilebhisi ikhipha isiphuzo ekucindezelweni kwegazi kanye nezimpawu zomzimba kubantu abane-pre-hypertension: okungahleliwe, okuyimpumputhe, izingalo ezimbili, okufanayo, i-placebo -ilingo elilawulwayo. UBr J Nutriti. 2016; 115: 226-38. Buka okungaqondakali.
    14. UPatrizi A, uRaone B, uNeri I, et al. Ukuhlolwa komtholampilo okungahleliwe, okulawulwayo, okungaboni kabili okuhlola ukuphepha nokusebenza kokhilimu we-MD2011001 ku-atopic dermatitis emnene ukuya kokulinganisela yobuso nentamo ezinganeni, ebusheni nakubantu abadala. Ukuphathwa kwe-J Dermatolog. 2016; 27: 346-50. Buka okungaqondakali.
    15. ULamport DJ, uLawton CL, uMerat N, et al. Ijusi lamagilebhisi e-Concord, ukusebenza kwengqondo, nokusebenza kokushayela: i-12-wk, i-placebo elawulwa, isilingo se-crossover esingahleliwe komama bezingane eziyishumi nesishiyagalombili. Ngingu-J J Nutriti Womtholampilo. 2016; 103: 775-83. Buka okungaqondakali.
    16. UZhang H, Liu S, Li L, et al. Umthelela wembewu yamagilebhisi ukhipha ukwelashwa ekushintsheni kwengcindezi yegazi: Ukuhlaziywa kwemeta kwezilingo eziyi-16 ezilawulwa ngokungahleliwe. Imithi (iBaltimore). 2016; 95: e4247. Buka okungaqondakali.
    17. ILumsden AJ, Cooper JG. Ingozi yokuchofoza yamagilebhisi: isicelo sokuqwashisa. I-Arch Dis Ingane. U-2017; 102: 473-474. Buka okungaqondakali.
    18. USpettel S, uChughtai B, uFeustel P, uKaufman A, uLevin RM, uDe E. Isivivinyo esingahle senziwe ngokungahleliwe se-juice yamagilebhisi ama-antioxidants emadodeni anezimpawu eziphansi zomchamo. I-Neurourol Urodyn. 2013; 32: 261-5. Buka okungaqondakali.
    19. URazavi SM, uGholamin S, u-Eskandari A, et al. Ukukhishwa kwembewu yamagilebhisi abomvu kuthuthukisa amaphrofayili we-lipid futhi kunciphise i-lipoprotein ene-oxidized low-density ezigulini ezine-hyperlipidemia emnene. J Med Ukudla. 2013; 16: 255-8. Buka okungaqondakali.
    20. Wahner-Roedler DL, Bauer BA, Loehrer LL, Cha SS, Hoskin TL, Olson JE. Umphumela wokukhishwa kwembewu yamagilebhisi emazingeni e-estrogen wabesifazane be-postmenopausal: isifundo somshayeli. J Ukudla Suppl. 2014; 11: 184-97. Buka okungaqondakali.
    21. UChen WT, uYang TS, uKen HC, et al. Ukusebenza kwe-ejenti ye-herbal ejenti ye-MB-6 njengesijobelelo esingaba khona kumakhemikhali asuselwa ku-5-fluoracil asuselwa kumdlavuza we-colorectal. I-Nut Nut. 2014; 34: 585-94. Buka izifushaniso.
    22. UTerauchi M, Horiguchi N, Kajiyama A, et al. Imiphumela yenzalo yamagilebhisi i-proanthocyanidin ekhishwa kwizimpawu zokunqamuka kokuya esikhathini, ukwakheka komzimba, kanye nemingcele yenhliziyo kwabesifazane abaneminyaka ephakathi nendawo: isifundo somshayeli esilawulwa ngokungahleliwe, esiyimpumputhe, esilawulwa nge-placebo. Ukunqamuka kokuya esikhathini 2014; 21: 990-6. Buka okungaqondakali.
    23. IRas RT, iZock PL, iZebregs YE, et al. Umphumela wembewu yamagilebhisi e-polyphenol ecebile ekhishwa kumfutho wegazi we-ambulensi ezifundweni ezine-pre-and stage I hypertension. UBr J Nutriti 2013; 110: 2234-41. Buka okungaqondakali.
    24. U-O'Connor PJ, uCaravalho AL, i-Freese EC, uCureton KJ. Imiphumela yokusetshenziswa kwamagilebhisi kokuqina, ukulimala kwemisipha, imizwa, kanye nempilo ebonakalayo. I-Int J Sport Nutr Exerc Metab 2013; 23: 57-64. Buka okungaqondakali.
    25. UHemmati AA, uForoozan M, uHoushmand G, et al. Umphumela wezinhlamvu zembewu yamagilebhisi ukhipha u-2% kokhilimu ekwelapheni isilonda sokuhlinzwa IGlob J J Health Sci 2014; 7: 52-8. Buka okungaqondakali.
    26. Su T, Wilf P, Huang Y, Zhang S, Zhou Z. Umsuka wemvelo wezinhlobo ezithile zezithelo ezidumile. ISci Rep 2015; 5: 16794. Buka okungaqondakali.
    27. I-Krochmal A, Grierson W. Umlando omfishane wokutshalwa kwamagilebhisi e-United States. I-Econ Bot 1961; 15: 114-118.
    28. Lokhu P, Lacombe T, Thomas MR. Imvelaphi yomlando nokwehluka kofuzo kwamagilebhisi ewayini. Amathrendi Genet 2006; 22: 511-9. Buka okungaqondakali.
    29. UHodgson JM, uCroft KD, uWoodman RJ, et al. Imiphumela kavithamini E, uvithamini C nama-polyphenols esilinganisweni sokwehluka kwengcindezi yegazi: imiphumela yezilingo ezimbili ezilawulwa ngokungahleliwe. UBr J Nutriti. 2014; 112: 1551-61. Buka okungaqondakali.
    30. U-Amsellem M, Masson JM, Negui B, no-al. [Endotelon ekwelapheni izinkinga ze-venolymphatic ku-premenstrual syndrome. Isifundo seMulticenter ezigulini eziyi-165]. I-Tempo Medical 1987; 282: 46-51.
    31. UTebib K et al. Ama-tannins embewu yamagilebhisi e-Polymeric avimbela izinguquko ze-plasma cholesterol kumagundane aphakwe nge-cholesterol ephezulu. Ukudla Chem 1994; 49: 403-406.
    32. UCaillet, S., Salmieri, S., noLacroix, M. Ukuhlolwa kwezindawo ezinamandla zokuqothula izinto zamagilebhisi ezikhishwe ngamagilebhisi ngendlela esheshayo yemibala. I-Acta Horticulturae 2007; 744: 425-429.
    33. UNuttall SL, uKendall MJ, uBombardelli E, no-al. Ukuhlolwa komsebenzi we-antioxidant wokukhishwa kwembewu yamagilebhisi okujwayelekile, iLeucoselect. Ijenali ye-Clinical Pharmacology and Therapeutics 1998; 23: 385-389.
    34. UPiper, J., Kohler, S., Niestroj, M., noMalek, F. A. Ukwelashwa kokudla okwelashwa kweziguli ezinezifo zemithambo yegazi e-atherosclerotic kanye nomfutho wegazi ophakeme ngokusebenzisa uwoyela we-perilla nokukhishwa kwamagilebhisi amnyama njengokudla okudliwayo kwezinjongo ezikhethekile zezokwelapha. I-Diätetische Intervention mit Perilla-Öl und Rotweintrauben-Extrakt als ergänzende bilanzierte Diät bei Patienten mit atherosklerotischen Gefässerkrankungen und Bluthochdruck 2005; 20: 20-26.
    35. I-Pecking A, i-Desperez-Curely JP, ne-Megret G. OPC (i-Endotelon) ekwelapheni i-post-therapy lymphedemas yemikhawulo ephezulu. Int’l d'Antiologie 1989.
    36. Sarrat L. [Ukwelashwa kwezinkinga zokusebenza kwemilenze engezansi ngu-Endotelon, i-microangioprotector]. IBordeaux Med 1981; 14: 685-688.
    37. UParienti J noPareinti-Amsellem J. [Ama-edema asemva kokuhlukumezeka kwezemidlalo: isivivinyo esilawulwayo se-endotelon]. IGaz Med France 1983; 90: 231-235.
    38. UVerin MM, uVildy A, noMaurin JF. [I-Retinopathies ne-OPC]. IBordeaux Medicale 1978; 11: 1467-1474.
    39. I-Fromantin M. [OPC ekwelapheni ubuthakathaka be-capillary kanye ne-retinopathy kwabanesifo sikashukela. Iziphakamiso zamacala angama-26]. I-Med Int 1982; 16: 432-434.
    40. U-Arne JL. [Igalelo ekucwaningeni ama-oligomers we-procyanidolic: i-Endotelon ekuphindaphindeni kwesifo sikashukela (ngokusekelwe ezimeni ezingama-30).]. IGaz Med France 1982; 89: 3610-3614.
    41. I-Skarpan´ska-Stejnborn, A., Basta, P., Pilaczyn´ska-Szczesniak, L., ne-Horoszkiewicz-Hassan, M. ukwengezwa kwamagilebhisi amnyama kunciphisa ukucindezeleka kwe-oxidative yegazi ekuphenduleni ukuvivinya umzimba okunamandla. I-Biology Yezemidlalo 2010; 27: 41-46.
    42. Lafay, S., Jan, C., Nardon, K., Lemaire, B., Ibarra, A., Roller, M., Houvenaeghel, M., Juhel, C., noCara, L. Ukukhishwa kwamagilebhisi kuthuthukisa isimo se-antioxidant nokusebenza ngokomzimba kubagijimi besilisa abaphezulu. Ijenali yeSayensi Yezemidlalo Nezokwelapha 2009; 8: 468.
    43. ULesbre FX noTigaud JD. [Umphumela we-Endotelon kunkomba ye-capillary fragility yeqembu elicacisiwe elilawulwayo: iziguli ze-cirrhosis]. IGazethi yeMedale de France 1983; 90: 2333-2337.
    44. UDelacroix P. [Ucwaningo olubili oluyimpumputhe lwe-Endotelon ngokungasebenzi kahle okungamahlalakhona okungamahlalakhona] [okuhunyushwe kusuka eFrance]. ILa Revue de Medecine 1981; 31 (27-28): 1793-1802.
    45. I-Thebaut JF, i-Thebaut P, ​​ne-Vin F. Ukutadisha i-Endotelon ekubonisweni okusebenzayo kokungasebenzi kahle kwemithambo yegazi. Imiphumela yocwaningo oluphindwe kabili lweziguli ezingama-92. I-Gazette Medicale 1985; 92: 96-100.
    46. UDartenuc P, Marache P, noChoussat H. [Ukumelana neCapillary ku-geriatry. Ukufundwa kwe-microangioprotector: endotelon.]. IBordeaux Medicale 1980; 13: 903-907.
    47. U-Araghi-Niknam M, uHosseini S, uLarson D, no-al. Ukukhishwa kwegxolo likaphayini kunciphisa ukuhlanganiswa kweplatelet. I-Integr Med 2000; 2: 73-77.
    48. UMurgov, I., Acikbas, M., noNikolova, R. Umsebenzi we-Antimicrobial we-citric acid nembewu yamagilebhisi ekhishwe kuma-microorganisms we-pathogenic ne-lactobacilli. Imisebenzi Yesayensi ye-University of Food Technologies - Plovdiv 2008; 55: 367-372.
    49. Brito, FF., Martinez, A., Palacios, R., Mur, P., Gomez, E., Galindo, PA, Borja, J., noMartinez, J. Rhinoconjunctivitis kanye nesifuba somoya esibangelwa impova yemvini: umbiko wecala . J Ukungezwani komzimba ne-Immunol 1999; 103 (2 Pt 1): 262-266. Buka okungaqondakali.
    50. U-Yamakoshi, J., Kataoka, S., Koga, T., no-Ariga, T. Proanthocyanidin ocebile ovela embewini yamagilebhisi unciphisa ukukhula kwe-aortic atherosclerosis konogwaja abondliwe yi-cholesterol. I-Atherosclerosis 1999; 142: 139-149. Buka okungaqondakali.
    51. Usuku, A. P., Kemp, H. J., Bolton, C., Hartog, M., noStansbie, D. Umphumela wokusetshenziswa kwejusi yamagilebhisi ebomvu egxile kumandla we-serum antioxidant kanye ne-low-density lipoprotein oxidation. UMnu.Nutr.Metab 1997; 41: 353-357. Buka okungaqondakali.
    52. UBagchi, D., Garg, A., Krohn, R. L., Bagchi, M., Tran, M. X., no-Stohs, S. J. Oxygen amakhono okuqothula ama-vithamini C no-E mahhala, kanye nembewu yamagilebhisi i-proanthocyanidin ekhishwe ku-vitro. I-Res Commun Mol Pathol. Pharmacol 1997; 95: 179-189. Buka okungaqondakali.
    53. UHenriet, J. P. [Ukwehluleka kweVeno-lymphatic. Iziguli ezingama-4,729 ezelashwa nge-hormonal kanye ne-procyanidol oligomer therapy]. UPhlebologie. 1993; 46: 313-325. Buka okungaqondakali.
    54. UMaffei, Facino R., Carini, M., Aldini, G., Bombardelli, E., Morazzoni, P., noMorelli, R. Ama-radicals wamahhala enza isenzo sokulwa nemisebenzi ye-anti-enzyme yama-procyanidines avela ku-Vitis vinifera. Indlela yokwenza isenzo sabo sokuvikela i-capillary. Arzneimittelforschung. 1994; 44: 592-601. Buka okungaqondakali.
    55. UMarguerie, C. noDrouet, M. [Umsebenzi we-eosinophilic lung kumlimi wamagilebhisi: indima yama-sulfite]. Ukungezwani komzimba neImmunol. (EParis) 1995; 27: 163-167. Buka okungaqondakali.
    56. UFaircloth, D. E. noRobison, W. J. Ukuvinjelwa kwekolon sigmoid ngezimbewu zamagilebhisi. I-JAMA 11-27-1981; 246: 2430. Buka okungaqondakali.
    57. I-Lagrue, G., Olivier-Martin, F., ne-Grillot, A. [Ucwaningo lwemiphumela yama-procyanidol oligomers ekumelaneni kwe-capillary ku-hypertension nakuma-nephropathies athile (i-Author's transl)]. USem Hop 9-18-1981; 57 (33-36): 1399-1401. Buka okungaqondakali.
    58. Baruch, J. [Umphumela we-Endotelon ku-edema yangemva kokuhlinzwa. Imiphumela yocwaningo oluphindwe kabili ngokuqhathaniswa ne-placebo ezigulini ezingama-32 zesifazane]. U-Ann. Chir Plast. Isihlalo. 1984; 29: 393-395. Buka okungaqondakali.
    59. UCox, J. noGrigg, M. Ukuvinjelwa kwamathumbu amancane ngumvini ophelele. UJ Am Geriatr. ISoc 1986; 34: 550. Buka okungaqondakali.
    60. USoyeux, A., Seguin, J. P., Le, Devehat C., noBertrand, A. [Endotelon. I-retinopathy yesifo sikashukela kanye ne-hemorheology (isifundo sokuqala)]. Inkunzi.Soc Ophtalmol. 1987; 87: 1441-1444. Buka okungaqondakali.
    61. UCorbe, C., uBoissin, uJ. P., noSiou, A. [Umbono okhanyayo nokusakazwa kwama-chorioretinal. Ukufundwa komphumela wama-oligomers we-procyanidolic (Endotelon)]. UJ Fr. Ophtalmol. 1988; 11: 453-460. Buka okungaqondakali.
    62. UYamasaki, R., Dekio, S., noJidoi, J. Xhumana nedermatitis kusuka kumhlumela wamagilebhisi. Xhumana noDermatitis 1985; 12: 226-227. Buka okungaqondakali.
    63. UBoissin, J. P., Corbe, C., noSiou, A. [Ukusakazwa kwe-Chorioretinal nokukhazimulisa: ukusetshenziswa kwama-procyanidol oligomers (Endotelon)]. Inkunzi.Soc.Ophtalmol.Fr. 1988; 88: 173-179. Buka okungaqondakali.
    64. Meunier, M. T., Villie, F., Jonadet, M., Bastide, J., noBastide, P. Ukuvinjelwa kwe-angiotensin Ngiguqula i-enzyme ngama-flavanolic compounds: in vitro and in vivo studies. UPlanta Med 1987; 53: 12-15. Buka okungaqondakali.
    65. Ubusika, uC. K. noKurtz, P. H. Izici ezinomthelela ekuthini abasebenzi bezithelo zomvini babe nokuqubuka kwesikhumba. Inkunzi.Environ.Contam Toxicol. 1985; 35: 418-426. Buka okungaqondakali.
    66. UMcCurdy, SA, Wiggins, P., Schenker, MB, Munn, S., Shaieb, AM, Weinbaum, Z., Goldsmith, D., McGillis, ST, Berman, B., noSamuels, S. Ukuhlola i-dermatitis ku-epidemiologic izifundo: isifo sesikhumba somsebenzi phakathi kwabavuni bamagilebhisi notamatisi eCalifornia. Ngingu-J Ind. Medi 1989; 16: 147-157. Buka okungaqondakali.
    67. Chang, W. C. noHsu, F. L. Ukuvinjelwa kokuhlanganiswa kweplatelet kanye ne-arachidonate metabolism kuma-platelet ngama-procyanidins. Ama-Prostaglandins Leukot.Essent.Amafutha Acids 1989; 38: 181-188. Buka okungaqondakali.
    68. UBarona, J., Blesso, CN, Andersen, CJ, Park, Y., Lee, J., noFernandez, ukusetshenziswa kwe-ML Amagilebhisi kukhulisa izimpawu zokulwa nokuvuvukala futhi kuphakamisa i-nitric oxide synthase yomgogodla lapho kungekho i-dyslipidemias emadodeni ane-metabolic syndrome . Izakhamzimba. 2012; 4: 1945-1957. Buka okungaqondakali.
    69. UChuang, CC, Shen, W., Chen, H., Xie, G., Jia, W., Chung, S., noMcIntosh, MK Imiphumela ehlukile yempuphu yamagilebhisi kanye nokukhishwa kwayo ekubekezeleleni i-glucose nokuvuvukala okungapheli ku-high- amagundane akhuluphele akhuluphele. J Agric. Ukudla Chem 12-26-2012; 60: 12458-12468. Buka okungaqondakali.
    70. UBenjamin, S., Sharma, R., Thomas, S. S., noNainan, M. T. Ukukhishwa kwembewu yamagilebhisi njenge-ejenti yokuvuselela amandla: isifundo sokuqhathanisa se-vitro. J Contemp.Dent.Pract. 2012; 13: 425-430. Buka okungaqondakali.
    71. UDe, Groote D., Van, Belleghem K., Deviere, J., Van, Brussel W., Mukaneza, A., no-Amininejad, L. Umphumela wokutholwa kwe-resveratrol, i-resveratrol phosphate, ne-catechin-rich grape seed extract kuzimpawu zokuxineka kwe-oxidative kanye nokukhulunywa kofuzo ezifundweni zabantu abakhuluphele ngokweqile. U-Ann Nutr Metab 2012; 61: 15-24. Buka okungaqondakali.
    72. I-Islam, SM, Hiraishi, N., Nassar, M., Sono, R., Otsuki, M., Takatsura, T., Yiu, C., noTagami, J. In vitro umphumela we-hesperidin empandeni ye-dentin collagen ne-de. / ukwenziwa kabusha kwamaminerali. I-Dent.Mater.J 2012; 31: 362-367. Buka okungaqondakali.
    73. UTome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, no-Espin, JC Ukusetshenziswa kwesengezo sokukhishwa kwamagilebhisi okuqukethe i-resveratrol kunciphisa i-LDL ene-oxidized ne-ApoB ezigulini ezithola ukuvinjelwa okuyinhloko kwesifo senhliziyo: ukulandelwa okuphindwe kathathu, okuyizinyanga eziyisithupha, ukulawulwa kwe-placebo , ukulingwa okungahleliwe. Mol.Nutr Ukudla Res 2012; 56: 810-821. Buka okungaqondakali.
    74. URababah, TM, Al-u'datt, M., Almajwal, A., Brewer, S., Feng, H., Al-Mahasneh, M., Ereifej, K., noYang, W. Ukuhlolwa kwe-nutraceutical, izakhiwo ze-physiochemical and sensory of raisin jam. J Ukudla iSci 2012; 77: C609-C613. Buka okungaqondakali.
    75. UTome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA, no-Espin, I-JC Ukusetshenziswa konyaka owodwa kwe-nutraceutical yamagilebhisi equkethe i-resveratrol kuthuthukisa isimo sokuvuvukala kanye ne-fibrinolytic yeziguli ekuvikeleni okuyinhloko kwesifo senhliziyo. NginguJ Cardiol. 8-1-2012; 110: 356-363. Buka okungaqondakali.
    76. UCherniack, E. P. Umbono oshukumisa ingqondo wamajikijolo: iqhaza elingaba khona lama-polyphenols ezitshalo ekwelapheni ukuphazamiseka okuhlobene nobudala. U-Br J Nutriti 2012; 108: 794-800. Buka okungaqondakali.
    77. UFang, M., Liu, R., Xiao, Y., Li, F., Wang, D., Hou, R., noChen, J. Biomodification ku-dentin nge-crosslinker yemvelo kuthuthukise ama-resin-dentin bond. J Dent. 2012; 40: 458-466. Buka okungaqondakali.
    78. UGazzani, G., Daglia, M., noPapetti, A. Izakhi zokudla ezinomsebenzi wama-antaries. ICurr Opin Biotechnol. 2012; 23: 153-159. Buka okungaqondakali.
    79. UTrotta, M., Cesaretti, M., Conzi, R., Derchi, L. E., noBorgonovo, G. Owesilisa osekhulile onobuhlungu be-mesogastric. Ukuvinjelwa kwamathumbu amancane okubangelwa amagilebhisi amasha angaqinile. Ann Ann Emed. 2011; 58: e1-e2. Buka okungaqondakali.
    80. UVidhya, S., Srinivasulu, S., Sujatha, M., noMahalaxmi, S. Umphumela wokukhishwa kwembewu yamagilebhisi emandleni okuqina we-koqweqwe lwawo olune-bleached. I-Oper.Dent. 2011; 36: 433-438. Buka okungaqondakali.
    81. UHaniadka, R., Popouri, S., Palatty, P. L., Arora, R., noBaliga, M. S. Izitshalo zokwelapha njenge-antiemetics ekwelapheni umdlavuza: ukubuyekeza. I-Integr.Cancer Ther. 2012; 11: 18-28. Buka okungaqondakali.
    82. UPires, K. M., Valenca, S. S., Resende, A. C., Porto, L. C., Queiroz, E. F., Moreira, D. D., no-de Moura, R. S. Ukukhishwa kwesikhumba kwamagilebhisi kunciphise impendulo ye-oxidative ye-pulmonary kumagundane avezwe intuthu kagwayi. IMed Sci. Monit. 2011; 17: I-BR187-BR195. Buka okungaqondakali.
    83. UFeringa, H. H., Laskey, D. A., Dickson, J. E., noColeman, C. I. Umphumela wokukhishwa kwembewu yamagilebhisi kuzimpawu zomngcipheko wenhliziyo: ukuhlaziywa kwemeta kwezilingo ezilawulwa ngokungahleliwe. J Am Ukudla. 2011; 111: 1173-1181. Buka okungaqondakali.
    84. Li, Q. Z., Cho, H. S., Jeun, S. H., Kim, K. J., Choi, S. J., noSung, K. W. Imiphumela yembewu yamagilebhisi i-proanthocyanidin kuma-5-hydroxytryptamine receptors kumaseli we-NCB-20 neuroblastoma. Biol.Pharm Bull. 2011; 34: 1109-1115. Buka okungaqondakali.
    85. I-Pan, X., Dai, Y., Li, X., Niu, N., Li, W., Liu, F., Zhao, Y., no-Yu, Z. Ukuvinjelwa kokulimala kwegundane okwenziwe i-arsenic ngamagilebhisi imbewu ngqo ngokucindezela i-NADPH oxidase ne-TGF-beta / Smad activation. I-Toxicol.Appl.I-Pharmacol. 8-1-2011; 254: 323-331. Buka okungaqondakali.
    86. Su, X. noD'Souza, D. H. Imbewu yamagilebhisi ekhishwe ukulawula amagciwane angenele umuntu. I-Appl.Environ.Microbiol. 2011; 77: 3982-3987. Buka okungaqondakali.
    87. ULluis, L., Munoz, M., Nogues, MR, Sanchez-Martos, V., Romeu, M., Giralt, M., Valls, J., noSola, R. Ukuhlolwa kwe-Toxicology kokukhishwa okucebile kwe-procyanidin kusuka izikhumba zamagilebhisi nembewu. Ukudla Chem Toxicol. 2011; 49: 1450-1454. Buka okungaqondakali.
    88. URabe, E., Stucker, M., Esperester, A., Schafer, E., no-Ottillinger, B. Ukusebenza nokubekezelelana kokukhishwa kweqabunga lomvini obomvu ezigulini ezinenkinga yokungapheli kwemithambo yegazi - imiphumela yokuphindwe kabili- isifundo esilawulwa nge-placebo esiyimpumputhe. Eur.J Vasc.Endovasc.Surg. 2011; 41: 540-547. Buka okungaqondakali.
    89. URowe, C. A., Nantz, M. P., Nieves, C., Jr., West, R. L., noPercival, S. S. Ukusetshenziswa njalo kwejusi yama-concord yamagilebhisi kuzuzisa ukungavikeleki komuntu. J Med Ukudla 2011; 14 (1-2): 69-78. Buka okungaqondakali.
    90. U-Liu, T., Zhao, J., Li, H., noMa, L. Ukuhlolwa kokusebenza kwegciwane elilwa nesifo sokusha kwesibindi se-Vitis vinifer L. Molecules. 2010; 15: 7415-7422. Buka okungaqondakali.
    91. Ipaki, M. K., Ipaki, J. S., Cho, M. L., Oh, H. J., Heo, Y.J., Woo, YJ, Heo, YM, Park, MJ, Park, HS, Park, SH, Kim, HY, kanye no-Min, JK Grape seed proanthocyanidin extract (GSPE) ilawula ngokuhlukile i-Foxp3 (+) yokulawula ne-IL-17 ( +) I-pathogenic T cell ku-arthritis ezenzakalelayo. I-Immunol. 3-30-2011; 135 (1-2): 50-58. Buka okungaqondakali.
    92. UDohadwala, MM, Hamburg, NM, Holbrook, M., Kim, BH, Duess, MA, Levit, A., Titas, M., Chung, WB, Vincent, FB, Caiano, TL, Frame, AA, Keaney, JF , Jr., neVita, JA Imiphumela Yomsizi wamagilebhisi weConcord kumfutho wegazi ophuthumayo ekubhekaneni nomfutho wegazi ophakeme kanye nesigaba 1 somfutho wegazi ophezulu. NginguJ J Clin. 2010; 92: 1052-1059. Buka okungaqondakali.
    93. Okuhlaza okotshani, B., Yao, X., Ganguly, A., Xu, C., Dusevich, V., Walker, MP, noWang, Y. Imbewu yamagilebhisi i-proanthocyanidins yandisa ukumelana kwe-collagen biodegradation ku-dentin / interface yokunamathisela lapho ifakiwe isinamathelisi. J Dent. 2010; 38: 908-915. Buka okungaqondakali.
    94. van Mierlo, L. A., Zock, P. L., van der Knaap, H. C., noDraijer, R. Amagilebhisi polyphenols akaphazamisi ukusebenza kwemithambo emadodeni aphilile. J Umsoco. 2010; 140: 1769-1773. Buka okungaqondakali.
    95. UZhang, F. J., Yang, J. Y., Mou, Y.H, Sun, B. S., Wang, J. M., noWu, C. F. Oligomer ama-procyanidins avela embewini yamagilebhisi enza ukuba kufe iseli elihleliwe elifana neparaptosis kumaseli e-glioblastoma U-87. I-Pharm Biol. 2010; 48: 883-890. Buka okungaqondakali.
    96. Khoshbaten, M., Aliasgarzadeh, A., Masnadi, K., Farhang, S., Tarzamani, MK, Babaei, H., Kiani, J., Zaare, M., noNajafipoor, F. Amagilebhisi akhipha imbewu ukwenza ngcono isibindi ukusebenza ezigulini ezinoshintsho lwesibindi esinamafutha esingena-alcohol. I-Saudi. J Gastroenterol. 2010; 16: 194-197. Buka okungaqondakali.
    97. Uchino, R., Madhyastha, R., Madhyastha, H., Dhungana, S., Nakajima, Y., Omura, S., kanye noMaruyama, M. NFkappaUmthethonqubo oncike ku-B we-activator ye-urokinase plasminogen yi-proanthocyanidin-rich rich seed seed extract : umphumela ekuhlaselweni ngamangqamuzana omdlavuza wesibeletho. Igazi Coagul. Fibrinolysis 2010; 21: 528-533. Buka okungaqondakali.
    98. UHollis, J. H., Houchins, J. A., Blumberg, J. B., noMattes, R. D. Imiphumela yejusi yamagilebhisi evumelana nokudla, ukudla, isisindo somzimba, iphrofayili ye-lipid, kanye nesimo se-antioxidant sabantu abadala. UJ Am Coll. Umsoco. U-2009; 28: 574-582. Buka okungaqondakali.
    99. U-Oliveira-Freitas, V. L., Dalla, Costa T., Manfro, R. C., Cruz, L. B., noSchwartsmann, G. Ithonya lejusi lomvini onsomi ku-cyclosporine bioavailability. UJ Ren Nutriti. 2010; 20: 309-313. Buka okungaqondakali.
    100. I-Ingersoll, GL, Wasilewski, A., Haller, M., Pandya, K., Bennett, J., He, H., Hoffmire, C., noBerry, C. Umphumela wejusi lamagilebhisi we-concord ku-nausea eyenziwe ngamakhemikhali kanye ukuhlanza: imiphumela yocwaningo lomshayeli wendiza. Iforamu le-Oncol.Nurs. 2010; 37: 213-221. Buka okungaqondakali.
    101. Hashemi, M., Kelishadi, R., Hashemipour, M., Zakerameli, A., Khavarian, N., Ghatrehsamani, S., no-Poursafa, P. Imiphumela emibi nesikhathi eside samagilebhisi nepomegranati ukusetshenziswa kwejusi ekusebenzeni kabusha kwemithambo yegazi. ku-syndrome ye-metabolic syndrome yezingane. UCardiol Omncane. 2010; 20: 73-77. Buka okungaqondakali.
    102. IMatias, AA, Serra, AT, Silva, AC, Perdigao, R., Ferreira, TB, Marcelino, I., Silva, S., Coelho, AV, Alves, PM, kanye noDuarte, izinsalela ze-CM zokwenza iwayini njengomthombo ongaba khona kwama-anti-adenoviral agents wemvelo. Int. J Ukudla iSci. 2010; 61: 357-368. Buka okungaqondakali.
    103. Kamiyama, M., Kishimoto, Y., Tani, M., Andoh, K., Utsunomiya, K., noKondo, K. Ukuvinjelwa kwe-low-density lipoprotein oxidation yi-Nagano purple grape (Vitis viniferaxVitis labrusca). J Izakhi. I -ci. Vitaminol. (Tokyo) 2009; 55: 471-478. Buka okungaqondakali.
    104. UKrikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., noJoseph, J. A. Concord juice juice supplementation ithuthukisa ukusebenza kwememori kubantu abadala asebekhulile abanokukhubazeka okuncane kwengqondo. UBr J Nutriti. 2010; 103: 730-734. Buka okungaqondakali.
    105. I-La, V. D., Bergeron, C., Gafner, S., ne-Grenier, D. Ukukhishwa kwembewu yamagilebhisi kucindezela ukuvinjelwa kwe-lipopolysaccharide-induction matrix metalloproteinase (MMP) ngama-macrophages futhi kuvimbela imisebenzi yabantu ye-MMP-1 ne -9. J Isikhathi. U-2009; 80: 1875-1882. Buka okungaqondakali.
    106. UKim, E. J., Park, H., Park, S. Y., Jun, J. G., noPark, J. H. Ingxenye yamagilebhisi i-piceatannol iheha i-apoptosis kuma-DU145 amangqamuzana omdlavuza wesibeletho womuntu ngokusebenzisa ukwenziwa kwezindlela zangaphandle nezangaphakathi. J Med Ukudla 2009; 12: 943-951. Buka okungaqondakali.
    107. Hsu, Y. L., Liang, H. L., Hung, C. H., no Kuo, P. L. Syringetin, isithako esenziwe nge-flavonoid esivinini nasewayinini, senza ukwehlukaniswa kwabantu nge-osteoblast ngokusebenzisa ithambo le-morphogenetic protein-2 / extracellular signal-regated kinase 1/2 pathway. I-Mol.Nutr.Food Res 2009; 53: 1452-1461. Buka okungaqondakali.
    108. Park, Y. K., Lee, S. H., Park, E., Kim, J. S., noKang, M. H. Izinguquko esimweni se-antioxidant, umfutho wegazi, kanye nokulimala kwe-DNA ye-lymphocyte kusuka ekusetshenzisweni kwejusi lamagilebhisi. UMnu.N.Y.Acad.Sci. 2009; 1171: 385-390. Buka okungaqondakali.
    109. UKar, P., Laight, D., Rooprai, HK, Shaw, KM, noCummings, M. Imiphumela yokukhishwa kwembewu yamagilebhisi kuhlobo lwesi-2 lwezifo zesifo sikashukela engozini enkulu yenhliziyo: i-doublebo blind blind randomized trial trial ehlola izimpawu ze-metabolic, vascular ithoni, ukuvuvukala, ukucindezeleka okwenziwe nge-oxidative nokuzwela kwe-insulin. Isifo sikashukela. 2009; 26: 526-531. Buka okungaqondakali.
    110. USandra, D., Radha, M., Harishkumar, M., Yuichi, N., Sayuri, O., noMasugi, M. Downregulation we-urokinase-type plasminogen activator kanye ne-plasminogen activator inhibitor-1 ngembewu yamagilebhisi proanthocyanidin ekhishwe. I-Phytomedicine. 2010; 17: 42-46. Buka okungaqondakali.
    111. USivaprakasapillai, B., Edirisinghe, I., Randolph, J., Steinberg, F., noKappagoda, T. Umphumela wembewu yamagilebhisi ekhishwa kumfutho wegazi ezifundweni ezine-metabolic syndrome. I-Metabolism 2009; 58: 1743-1746. Buka okungaqondakali.
    112. U-Wang, YJ, Thomas, P., Zhong, JH, Bi, FF, Kosaraju, S., Pollard, A., Fenech, M., noZhou, ukusetshenziswa kwe-XF kwembewu yamagilebhisi kuvimbela ukubekwa kwe-amyloid-beta futhi kunciphisa ukuvuvukala ubuchopho begundane lesifo i-Alzheimer's. Neurotox. 2009; 15: 3-14. Buka okungaqondakali.
    113. I-Hsu, i-C. I-Anticancer Res 2009; 29: 283-289. Buka okungaqondakali.
    114. I-Cheah, KY, Howarth, GS, Yazbeck, R., Wright, TH, Whitford, EJ, Payne, C., Butler, RN, neBastian, SE Amagilebhisi akhipha imbewu evikela amaseli e-IEC-6 kwi-cytotoxicity eyenziwe ngamakhemikhali futhi enza ngcono amapharamitha we-mucositis omncane wamathumbu kumagundane ane-mucositis eyenziwe ngokuzama. I-Cancer Biol. Ngo-2009; 8: 382-390. Buka okungaqondakali.
    115. UCastillo-Pichardo, L., Martinez-Montemayor, M. M., Martinez, J. E., Wall, K. M., Cubano, L. A., noDharmawardhane, S. Ukuvinjelwa kokukhula kwesimila se-mammary kanye ne-metastases ethanjeni nasesibindi ngama-polyphenols wamagilebhisi okudla. I-Clin.Exp. Metastasis 2009; 26: 505-516. Buka okungaqondakali.
    116. URao, A. V., Shen, H., Agarwal, A., Yatcilla, M. T., no-Agarwal, S. Bioabsorption kanye naku-vivo antioxidant izakhiwo zomvini ezikhipha i-biovin ((r)): isifundo sokungenelela komuntu. J Med Ukudla 2000; 3: 15-22. Buka okungaqondakali.
    117. UZhang, FJ, Yang, JY, Mou, YH, Sun, BS, Ping, YF, Wang, JM, Bian, XW, noWu, CF Inhibition of U-87 human glioblastoma cell proliferation and formyl peptide receptor function by oligomer procyanidins ( F2) ehlukaniswe nembewu yamagilebhisi. I-Chem Biol. Ukuxhumana. 5-15-2009; 179 (2-3): 419-429. Buka okungaqondakali.
    118. UWen, W., Lu, J., Zhang, K., noChen, S. Ukukhishwa kwembewu yamagilebhisi kuvimbela i-angiogenesis ngokucindezelwa kwendlela yokufaka uphawu yemithambo ye-endothelial grow factor signaling. I-Cancer Prev. Res (Phila) 2008; 1: 554-561. Buka okungaqondakali.
    119. U-Leifert, W. R. no-Abeywardena, M. Y. Imbewu yamagilebhisi newayini elibomvu i-polyphenol extracts zivimbela ukutholwa kwe-cholesterol yeselula, ukwanda kweseli, nomsebenzi we-5-lipoxygenase. Umsoco. 2008; 28: 842-850. Buka okungaqondakali.
    120. UXie, Q., Bedran-Russo, A. K., noWu, C. D. In vitro remineralization imiphumela yokukhipha imbewu yamagilebhisi kuzimpande zokufakelwa. J Dent. 2008; 36: 900-906. Buka okungaqondakali.
    121. UChaves, A. A., Joshi, M. S., Coyle, C. M., Brady, J. E., Dech, S. J., Schanbacher, B. L., Baliga, R., Basuray, A., noBauer, J. A. Vasoprotective endothelial imiphumela yomkhiqizo omile wamagilebhisi kubantu. IVascul. Ikhemisi. 2009; 50 (1-2): 20-26. Buka okungaqondakali.
    122. U-Liu, J. Y. no-Zhong, J. Y. [Funda ngomphumela wokuvikela wama-procyanidin wamagilebhisi ekulimaleni ngemisebe kubantu abaxhunywe ngemisebe]. Zhonghua Yu Fang Yi.Ingxoxo.Za Zhi. 2008; 42: 264-267. Buka okungaqondakali.
    123. UPunathil, T. noKatiyar, S. K. Ukuvinjelwa kokufuduka kwamangqamuzana omdlavuza wamangqamuzana okungewona omncane ngembewu yamagilebhisi i-proanthocyanidins kulungiswa ngokuvimbela i-nitric oxide, i-guanylate cyclase, ne-ERK1 / 2. UMol.Carcinog. U-2009; 48: 232-242. Buka okungaqondakali.
    124. UMahadeswaraswamy, Y. H., Nagaraju, S., Girish, K. S., noKemparaju, K. Ukubhujiswa kwezicubu zasendaweni nezakhiwo ze-procoagulation ze-Echis carinatus venom: inhibition by Vitis vinifera seed methanol extract. I-Phytother.I-2008; 22: 963-969. Buka okungaqondakali.
    125. Jimenez, JP, Serrano, J., Tabernero, M., Arranz, S., Diaz-Rubio, ME, Garcia-Diz, L., Goni, I., noSaura-Calixto, F. Imiphumela yamagilebhisi e-antioxidant fiber kwizifo ezinobungozi besifo senhliziyo. Ukudla okunempilo 2008; 24 (7-8): 646-653. Buka okungaqondakali.
    126. UCastilla, P., Davalos, A., Teruel, JL, Cerrato, F., Fernandez-Lucas, M., Merino, JL, Sanchez-Martin, CC, Ortuno, J., noLasuncion, MA Imiphumela yokuqhathanisa yokwengeza kokudla ngejusi yamagilebhisi abomvu novithamini E ekukhiqizeni i-superoxide ngokusabalalisa i-neutrophil NADPH oxidase ezigulini ze-hemodialysis. NginguJ J Clin. 2008; 87: 1053-1061. Buka okungaqondakali.
    127. Kuo, P. L. noHsu, Y. L. I-piceatannol yamagilebhisi newayini ivimbela ukwanda kwamangqamuzana omdlavuza wesinye somuntu ngokuvimba ukuqhubekela phambili komjikelezo weseli nokunciphisa indlela ye-Fas ligand-mediated apoptotic. I-Mol.Nutr.Food Res 2008; 52: 408-418. Buka okungaqondakali.
    128. U-Olas, B., Wachowicz, B., Tomczak, A., Erler, J., Stochmal, A., no-Oleszek, W. Ukuqhathanisa i-anti-platelet kanye ne-antioxidant izakhiwo zezinto ezicebile ze-polyphenol ezivela: amajikijolo e-Aronia melanocarpa, imbewu yamagilebhisi namagxolo we-Yucca schidigera in vitro. Amaplatelets. 2008; 19: 70-77. Buka okungaqondakali.
    129. UKoo, M., Kim, SH, Lee, N., Yoo, MY, Ryu, SY, Kwon, DY, noKim, YS 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) ukunciphisa umphumela wokuvimbela weVitis vinifera . UFitoterapia 2008; 79: 204-206. Buka okungaqondakali.
    130. Engelbrecht, AM, Mattheyse, M., Ellis, B., Loos, B., Thomas, M., Smith, R., Peters, S., Smith, C., naseMyburgh, K. Proanthocyanidin ovela embewini yamagilebhisi Indlela ye-PI3-kinase / PKB futhi inciphisa i-apoptosis kulayini wesifo somdlavuza wekoloni. Umdlavuza Lett. 12-8-2007; 258: 144-153. Buka okungaqondakali.
    131. USano, A., Uchida, R., Saito, M., Shioya, N., Komori, Y., Tho, Y., noHashizume, N. Imiphumela ezuzisayo yokukhishwa kwembewu yamagilebhisi kwi-maldialdehyde-modified LDL. UJ Nutr Sci Vitaminol. (Tokyo) 2007; 53: 174-182. Buka okungaqondakali.
    132. I-Etheridge, AS, Black, SR, Patel, PR, So, J., and Mathews, JM An in vitro assessment of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, seed grape, milk thistle and ginseng extracts futhi izindawo zabo. UPlanta Med 2007; 73: 731-741. Buka okungaqondakali.
    133. de Lange, D. W., Verhoef, S., Gorter, G., Kraaijenhagen, R. J., van de Wiel, A., no-Akkerman, J. W. Polyphenolic amagilebhisi akhipha ukuvimbela ukusebenza kweplatelet nge-PECAM-1: incazelo yenkinga yaseFrance. Umtholampilo Wotshwala IExp .Res 2007; 31: 1308-1314. Buka okungaqondakali.
    134. UGamsky, T. E., McCurdy, S. A., Samuels, S. J., noSchenker, M. B. Kwehlisiwe i-FVC phakathi kwabasebenzi bamagilebhisi baseCalifornia. NginguMfu uRespir. Dis 1992; 145 (2 Pt 1): 257-262. Buka okungaqondakali.
    135. USamet, uJ. M. noCoultas, D. B. Kwehliswe amandla okuphoqelelwa kubasebenzi bamagilebhisi eCalifornia. Kusho ukuthini? NginguMfu uRespir. Dis 1992; 145 (2 Pt 1): 255-256. Buka okungaqondakali.
    136. U-Urios, P., Grigorova-Borsos, A. M., noSternberg, M. Flavonoids bavimbela ukwakheka kwe-AGE pentosidine e-collagen efakwe i-glucose, ngokwesakhiwo sayo. I-Eur J Nutriti 2007; 46: 139-146. Buka okungaqondakali.
    137. U-Agarwal, C., Veluri, R., Kaur, M., Chou, SC, Thompson, JA, no-Agarwal, R. Ukwehlukaniswa kwama-tannins esisindo samangqamuzana aphezulu ekukhipheni imbewu yamagilebhisi nokuhlonza i-procyanidin B2-3,3'-di -O-gallate njengengxenye enkulu esebenzayo ebangela ukukhula kokuvimbela kanye nokufa kwe-apoptotic kwamangqamuzana e-DU145 womuntu wesifo secancer. ICarcinogenesis 2007; 28: 1478-1484. Buka okungaqondakali.
    138. UKaur, M., Singh, R. P., Gu, M., Agarwal, R., no-Agarwal, C. Ukukhishwa kwembewu yamagilebhisi kuvimbela i-vitro nokukhula kwe-vivo kwamangqamuzana e-carcinoma womuntu. ICancer Cancer Res 10-15-2006; 12 (20 Pt 1): 6194-6202. Buka okungaqondakali.
    139. Ukubuyekezwa kobufakazi kukhishwe iqabunga lomvini obomvu ekuvikeleni nasekulawuleni izifo eziyingozi. J Ukunakekelwa Kwamanxeba 2006; 15: 393-396. Buka okungaqondakali.
    140. I-Suppasrivasuseth, J., Bellantone, R. A., Plakogiannis, F. M., neStagni, G. Permeability kanye nokugcinwa kwezifundo ze (-) epicatechin gel formulations in human cadaver skin. Izidakamizwa Dev Ind Pharm 2006; 32: 1007-1017. Buka okungaqondakali.
    141. UCastilla, P., Echarri, R., Davalos, A., Cerrato, F., Ortega, H., Teruel, JL, Lucas, MF, Gomez-Coronado, D., Ortuno, J., noLasuncion, MA bagxile Ijusi lamagilebhisi elibomvu linemiphumela ye-antioxidant, hypolipidemic, kanye ne-antiinfigueatory kuzo zombili iziguli ze-hemodialysis nezihloko ezinempilo. NginguJ J Clin. 2006; 84: 252-262. Buka okungaqondakali.
    142. UDavalos, A., Fernandez-Hernando, C., Cerrato, F., Martinez-Botas, J., Gomez-Coronado, D., Gomez-Cordoves, C., noLasuncion, i-MA Red grape juice polyphenols bashintsha i-cholesterol homeostasis futhi ukwandisa umsebenzi we-LDL-receptor kumaseli womuntu ku-vitro. J Umsoco. 2006; 136: 1766-1773. Buka okungaqondakali.
    143. UKaur, M., Agarwal, R., no-Agarwal, C. Ukukhishwa kwembewu yamagilebhisi kukhuthaza i-anoikis kanye ne-caspase-mediated apoptosis kumaseli womuntu wesifo se-prostate carcinoma ama-LNCaP: iqhaza elingaba khona le-ataxia telangiectasia mutated-p53 activation. UMol.Cancer Ther 2006; 5: 1265-1274. Buka okungaqondakali.
    144. USkovgaard, G. R., Jensen, A. S., noSigler, M. L. Umphumela wesengezo sokudla senoveli ekugugeni kwesikhumba kwabesifazane abangemva kokuya esikhathini. I-Eur J Clin Nutrite 2006; 60: 1201-1206. Buka okungaqondakali.
    145. UMantena, S. K., Baliga, M. S., noKatiyar, S. K. Imbewu yamagilebhisi i-proanthocyanidins yenza i-apoptosis futhi ivimbele i-metastasis yamaseli e-metastatic webele carcinoma. ICarcinogenesis 2006; 27: 1682-1691. Buka okungaqondakali.
    146. Brooker, S., Martin, S., Pearson, A., Bagchi, D., Earl, J., Gothard, L., Hall, E., Porter, L., no-Yarnold, J. Ababili abayizimpumputhe, i-placebo -ukulawulwa, okungahleliwe kwesigaba sesibili sesivivinyo se-IH636 seed seed proanthocyanidin extract (GSPE) ezigulini ezine-radiation induction induction. I-Radiother.Oncol 2006; 79: 45-51. Buka okungaqondakali.
    147. Monsieur, R. noVan, Snick G. [Ukusebenza kweqabunga elibomvu lomvini kukhipha i-AS 195 ku-Chronic Venous Insufficiency]. UPraxis. (UBern. 1994.) 1-25-2006; 95: 187-190. Buka okungaqondakali.
    148. UVeluri, R., Singh, RP, Liu, Z., Thompson, JA, Agarwal, R., no-Agarwal, C. Ukwehlukaniswa kokukhishwa kwembewu yamagilebhisi kanye nokuhlonza i-gallic acid njengenye yezinto ezinkulu ezisebenzayo ezibangela ukuvinjelwa kokukhula kanye ne-apoptotic ukufa kwamangqamuzana e-DU145 womuntu we-prostate carcinoma. ICarcinogenesis 2006; 27: 1445-1453. Buka okungaqondakali.
    149. Barthomeuf, C., Lamy, S., Blanchette, M., Boivin, D., Gingras, D., noBeliveau, R. Ukuvinjelwa kwe-sphingosine-1-phosphate- kanye ne-vascular endothelial growth factor-indosed endothelial cell chemotaxis ngokubomvu i-polyphenols yesikhumba samagilebhisi ihambisana nokuncipha kwe-synthesis yeplatelet-activating factor synthesis. I-Radic yamahhala. I-Biol.Med 2-15-2006; 40: 581-590. Buka okungaqondakali.
    150. Lekakis, J., Rallidis, LS, Andreadou, I., Vamvakou, G., Kazantzoglou, G., Magiatis, P., Skaltsounis, AL, and Kremastinos, DT Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary Isifo senhliziyo. I-Eur.J Cardiovasc.Prev. Ukuvuselelwa. 2005; 12: 596-600. Buka okungaqondakali.
    151. I-Tao, HY, Wu, CF, Zhou, Y., Gong, WH, Zhang, X., Iribarren, P., Zhao, YQ, Le, YY, noWang, JM Ingxenye yamagilebhisi i-resveratrol iphazamisa umsebenzi wama-receptors we-chemoattractant kuma-leukocyte e-phagocytic. Iseli Mol.Immunol. 2004; 1: 50-56. Buka okungaqondakali.
    152. UVitseva, O., Varghese, S., Chakrabarti, S., Folts, J. D., noFreedman, J. E. Amagilebhisi nembewu yesikhumba kuvimbela ukusebenza kweplatelet kanye nokukhishwa kwama-intermediate oxygen asebenzayo. J Cardiovasc.I-Pharmacol. 2005; 46: 445-451. Buka okungaqondakali.
    153. UCoimbra, S. R., Lage, S. H., Brandizzi, L., Yoshida, V., noDa Luz, P. L. Isenzo sewayini elibomvu nejusi lamagilebhisi elibubende ku-reactivity ye-vascular sizimele nge-plasma lipids ezigulini ze-hypercholesterolemic. I-Braz. J Med Biol. I-2005; 38: 1339-1347. Buka okungaqondakali.
    154. UZern, TL, Wood, RJ, Greene, C., West, KL, Liu, Y., Aggarwal, D., Shachter, NS, noFernandez, ML Amagilebhisi ama-polyphenols enza umphumela wokuvikela inhliziyo kwabesifazane bangaphambi nangemva kokuya esikhathini ngokunciphisa iplasma lipids nokunciphisa ukucindezeleka okwenziwe nge-oxidative. J Umsoco. 2005; 135: 1911-1917. Buka okungaqondakali.
    155. USharma, S. D. noKatiyar, S. K. Dietary grape-seed proanthocyanidin inhibition of ultraviolet B-induced immune suppression ihlotshaniswa nokwenziwa kwe-IL-12. ICarcinogenesis 2006; 27: 95-102. Buka okungaqondakali.
    156. UHansen, A. S., Marckmann, P., Dragsted, L. O., Finne Nielsen, I. L., Nielsen, S. E., noGronbaek, M. Umphumela wewayini elibomvu nokukhishwa kwamagilebhisi abomvu kuma-lipids egazi, izici ze-haemostatic, nezinye izinto ezinobungozi zesifo senhliziyo. Umtholampilo wase-Eur. J. 2005; 59: 449-455. Buka okungaqondakali.
    157. UPark, Y. K., Kim, J. S., noKang, M. H. Concord ijusi lamagilebhisi ukwengeza kunciphisa ukucindezelwa kwegazi emadodeni aseKorea ane-hypertensive: isivivinyo sokungenelela esilawulwa kabili. Ama-Biofactors 2004; 22 (1-4): 145-147. Buka okungaqondakali.
    158. de Lange, D. W., Scholman, W. L., Kraaijenhagen, R. J., Akkerman, J. W., novan van Wiel, A. Utshwala kanye ne-polyphenolic grape extract kuvimbela ukunamathela kweplatelet egazini eligelezayo. I-Eur.J Clin. Invest 2004; 34: 818-824. Buka okungaqondakali.
    159. Yamakoshi, J., Sano, A., Tokutake, S., Saito, M., Kikuchi, M., Kubota, Y., Kawachi, Y., no-Otsuka, F. Ukudla ngomlomo kokukhishwa okucebile kwe-proanthocyanidin embewini yamagilebhisi. ithuthukisa i-chloasma. I-Phytother Res 2004; 18: 895-899. Buka okungaqondakali.
    160. UClifton, P. M. Umphumela wokukhishwa kwembewu yamagilebhisi kanye neQuercetin kumapharamitha we-Cardiovascular kanye ne-Endothelial ePhalamende. J Biomed. I-Biotechnol. 2004; 2004: 272-278. Buka okungaqondakali.
    161. U-Albers, A. R., Varghese, S., Vitseva, O., Vita, J. A., noFreedman, J. E. Imiphumela yokulwa nokuvuvukala yokusetshenziswa kwejusi lomvini onsomi ezihlokweni ezinesifo esizinzile semithambo yegazi. I-Arterioscler.Ibhomu.Vasc.Ibhayisikili. 2004; 24: e179-e180. Buka okungaqondakali.
    162. UNishikawa, M., Ariyoshi, N., Kotani, A., Ishii, I., Nakamura, H., Nakasa, H., Ida, M., Nakamura, H., Kimura, N., Kimura, M., UHasegawa, A., Kusu, F., Ohmori, S., Nakazawa, K., noKitada, M. Imiphumela yokungenisa okuqhubekayo kwetiye eluhlaza noma okukhishwe imbewu yamagilebhisi kuma-pharmacokinetics e-midazolam. Izidakamizwa Metab Pharmacokinet. 2004; 19: 280-289. Buka okungaqondakali.
    163. UBejaoui, H., Mathieu, F., Taillandier, P., noLebrihi, A. Ochratoxin Ukususwa kumajusi omvini wokwenziwa nowemvelo ngezinhlobo ezikhethiwe ze-oenological Saccharomyces. J Appl, iMicrobiol. 2004; 97: 1038-1044. Buka okungaqondakali.
    164. UNomoto, H., Iigo, M., Hamada, H., Kojima, S., noTsuda, H. Chemoprevention of colorectal cancer by grape seed proanthocyanidin kuhambisana nokwehla kokwanda nokwanda kwe-apoptosis. I-Cancer Cancer 2004; 49: 81-88. Buka okungaqondakali.
    165. UWard, N. C., Croft, K. D., Puddey, I. B., noHodgson, J. M. Supplementation on grape seed polyphenols kubangela ukwanda kokukhishwa komchamo kwe-3-hydroxyphenylpropionic Acid, i-metabolite ebalulekile yama-proanthocyanidins ebantwini. J Agric. Ukudla Chem 8-25-2004; 52: 5545-5549. Buka okungaqondakali.
    166. I-Larrosa, M., Tomas-Barberan, F. A., ne-Espin, J. C. Amagilebhisi newayini i-polyphenol piceatannol iyisisusa esinamandla se-apoptosis kumaseli womuntu we-SK-Mel-28 melanoma. Eur. J Umsoco. 2004; 43: 275-284. Buka okungaqondakali.
    167. Kalus, U., Koscielny, J., Grigorov, A., Schaefer, E., Peil, H., noKiesewetter, H.Ukuthuthukiswa kokuhlinzekwa kwe-microcirculation cutaneous kanye ne-oxygen ezigulini ezinesifo esingapheliyo semithambo ekhishwe ngomlomo womvini obomvu ishiya AS 195: isifundo esingahleliwe, esingaboni kabili, esilawulwa nge-placebo, isifundo se-crossover. Izidakamizwa iRD 2004; 5: 63-71. Buka okungaqondakali.
    168. URosa, C. A., Magnoli, C. E., Fraga, M. E., Dalcero, A. M., noSantana, D. M. Ukutholakala kwe-ochratoxin A ewayinini nejusi lamagilebhisi elimakethwa eRio de Janeiro, eBrazil. Isengezo Sokudla.Contam 2004; 21: 358-364. Buka okungaqondakali.
    169. URawn, D.F, Roscoe, V., Krakalovich, T., noHanson, C. Ukugxila kwe-N-methyl carbamate kanye nokulinganiselwa kokudla kwe-apula namajusi wamagilebhisi atholakala emakethe yokuthengisa eCanada. Isengezo Sokudla.Contam 2004; 21: 555-563. Buka okungaqondakali.
    170. UVayalil, PK, Mittal, A., noKatiyar, SK Proanthocyanidins ovela embewini yamagilebhisi avimbela ukubonakaliswa kwe-matrix metalloproteinases kumaseli womuntu we-prostate carcinoma, ehambisana nokuvinjelwa kokusebenza kwe-MAPK ne-NF kappa B. Carcinogenesis 2004; 25: 987- 995. Buka okungaqondakali.
    171. IVigna, GB, Costantini, F., Aldini, G., Carini, M., Catapano, A., Schena, F., Tangerini, A., Zanca, R., Bombardelli, E., Morazzoni, P., Mezzetti , A., Fellin, R., noMaffei, Facino R. Umphumela wokukhishwa kwembewu yamagilebhisi okulinganiselwe ku-low-density lipoprotein susceptibility to oxidation in smoker heavy. I-Metabolism 2003; 52: 1250-1257. Buka okungaqondakali.
    172. UDhanalakshmi, S., Agarwal, R., no-Agarwal, C. Ukuvinjelwa kwendlela ye-NF-kappaB embewini yamagilebhisi yokufa kwe-apoptotic eyenziwe ngamaseli e-prostate carcinoma DU145. Int J Oncol. 2003; 23: 721-727. Buka okungaqondakali.
    173. Schaefer, E., Peil, H., Ambrosetti, L., noPetrini, O. Edema izakhiwo zokuvikela iqabunga lomvini obomvu likhipha i-AS 195 (i-Folia vitis viniferae) ekwelapheni ukungasebenzi kahle okungapheli. Isivivinyo somtholampilo sokubheka amasonto ayisithupha. Arzneimittelforschung. 2003; 53: 243-246. Buka okungaqondakali.
    174. UTyagi, A., Agarwal, R., no-Agarwal, C. Ukukhishwa kwembewu yamagilebhisi kuvimbela ukusayinwa kwe-mitogenic okwenziwe yi-EGF futhi kusebenza ngokuqinile kepha kusebenze i-JNK kumaseli womuntu wendlala ye-prostate carcinoma DU145: iqhaza elingaba khona ekunqandeni ukuchitheka komzimba kanye ne-apoptosis. U-Oncogene 3-6-2003; 22: 1302-1316. Buka okungaqondakali.
    175. UKatsuzaki, H., Hibasami, H., Ohwaki, S., Ishikawa, K., Imai, K., Date, K., Kimura, Y., noKomiya, T. Cyanidin 3-O-beta-D-glucoside ehlukaniswe nesikhumba se-Black Glycine max namanye ama-anthocyanini ahlukaniswe nesikhumba samagilebhisi abomvu enza i-apoptosis kumaseli we-lymphoid leukemia Molt 4B. I-Oncol. 2003; 10: 297-300. Buka okungaqondakali.
    176. UNatella, F., Belelli, F., Gentili, V., Ursini, F., noScaccini, C. Imbewu yamagilebhisi i-proanthocyanidins ivimbela ukucindezeleka kwe-plasma postprandial oxidative kubantu. J Agric. Ukudla Chem 12-18-2002; 50: 7720-7725. Buka okungaqondakali.
    177. UShanmuganayagam, D., Beahm, M. R., Osman, H. E., Krueger, C. G., Reed, J. D., kanye namaFolts, J. D. Imbewu yamagilebhisi kanye nezikhumba zesikhumba samagilebhisi zenza umphumela omkhulu we-antiplatelet uma usetshenziswa ngokuhlangana kunalapho usetshenziswa ngamunye ezinjeni nakubantu. J Umsoco. 2002; 132: 3592-3598. Buka okungaqondakali.
    178. U-O'Byrne, D. J., Devaraj, S., Grundy, S. M., noJialal, I. Ukuqhathanisa imiphumela ye-antioxidant ye-Concord yamagilebhisi ijusi i-flavonoids i-alpha-tocopherol kwizimpawu zokucindezeleka kwe-oxidative kubantu abadala abaphilile. NginguJ J Clin. 2002; 76: 1367-1374. Buka okungaqondakali.
    179. U-Agarwal, C., Singh, R. P., no-Agarwal, R. Ukukhishwa kwembewu yamagilebhisi kudala ukufa kwe-apoptotic kwamaseli e-prostate carcinoma DU145 ngokusebenzisa i-caspases activation okuhambisana nokusabalalisa amandla we-membrane we-mitochondrial kanye ne-cytochrome c release. ICarcinogenesis 2002; 23: 1869-1876. Buka okungaqondakali.
    180. UChidambara Murthy, K. N., Singh, R. P., noJayaprakasha, G. K. Imisebenzi ye-Antioxidant yamagilebhisi (i-Vitis vinifera) i-pomace extracts. J Agric. Ukudla Chem 10-9-2002; 50: 5909-5914. Buka okungaqondakali.
    181. UNair, N., Mahajan, S., Chawda, R., Kandaswami, C., Shanahan, T. C., noSchwartz, S. A. Ukukhishwa kwembewu yamagilebhisi kusebenze ama-Th1 cell in vitro. I-Clin.Diagn.Lab Immunol. 2002; 9: 470-476. Buka okungaqondakali.
    182. Li, S., Zhong, J., noSun, F. [Funda ngomphumela wokuvikela wama-procyanidin wamagilebhisi ekulimaleni kwe-DNA okubangelwa yimisebe]. Zhonghua Yu Fang Yi.Ingxoxo.Za Zhi. 2000; 34: 131-133. Buka okungaqondakali.
    183. Chou, E. J., Keevil, J. G., Aeschlimann, S., Wiebe, D. A., Folts, J. D., noStein, J. H. Umphumela wokungenisa ijusi lomvini onsomi ekusebenzeni kokugcina kweziguli ezinesifo senhliziyo. Ngingu-J Cardiol 9-1-2001; 88: 553-555. Buka okungaqondakali.
    184. I-Banerjee, B. ne-Bagchi, D. Imiphumela ezuzisayo yenoveli ye-ih636 seed seed proanthocyanidin ekhishwe ekwelapheni i-pancreatitis engapheli. Ukugaya 2001; 63: 203-206. Buka okungaqondakali.
    185. URay, S. D., Parikh, H., Hickey, E., Bagchi, M., noBagchi, D. Imiphumela ehlukile ye-IH636 yamagilebhisi imbewu yama-proanthocyanidin ekhishwe kanye ne-DNA yokulungisa i-modulator 4-aminobenzamide ku-aniline hydroxylation yesibindi microsomal 4502E1. I-Mol Cell Biochem 2001; 218 (1-2): 27-33. Buka okungaqondakali.
    186. Omncane, J. F., Dragsted, L. O., Daneshvar, B., Lauridsen, S. T., Hansen, M., noSandstrom, B. Umphumela wokukhishwa kwesikhumba samagilebhisi esimweni se-oxidative. UBr J Nutr 2000; 84: 505-513. Buka okungaqondakali.
    187. I-Agarwal, C., Sharma, Y., Zhao, J., ne-Agarwal, R. Ingxenyenamba ye-polyphenolic evela embewini yamagilebhisi ibangela ukukhula okungaphenduki kokuvinjelwa kwamangqamuzana webele we-carcinoma MDA-MB468 ngokuvimbela ukusebenza kwe-mitogen-activated protein kinases activation kanye nokunciphisa ukuboshwa kwe-G1 umehluko. Umtholampilo I-Cancer Res 2000; 6: 2921-2930. Buka okungaqondakali.
    188. UCabras, P., Angioni, A., Caboni, P., Garau, V. L., Melis, M., Pirisi, F. M., noCabitza, F. Ukusatshalaliswa kwephephethi endaweni yamagilebhisi ngemuva kokwelashwa. J Agric. Ukudla Chem 2000; 48: 915-916. Buka okungaqondakali.
    189. Keevil, J. G., Osman, H. E., Reed, J. D., kanye namaFolts, J. D. Ijusi lamagilebhisi, kepha hhayi ijusi le-orange noma ijusi lamagilebhisi, livimbela ukuhlanganiswa kweplatelet yabantu. J Umsoco. 2000; 130: 53-56. Buka okungaqondakali.
    190. Ozturk, H. S., Kacmaz, M., Cimen, M. Y., noDurak, I. Iwayini elibomvu namagilebhisi amnyama aqinisa amandla e-antioxidant egazi. Ukudla okunomsoco 1999; 15 (11-12): 954-955. Buka okungaqondakali.
    191. I-Agarwal, C., Tyagi, A., ne-Agarwal, R. Gallic acid ibangela ukungasebenzi kwe-phosphorylation ye-cdc25A / cdc25C-cdc2 ngokusebenzisa ukusebenza kwe-ATM-Chk2, okuholela ekuboshweni komjikelezo weseli, futhi kuheha i-apoptosis kumaseli e-prostate carcinoma DU145 cell. UMol.Cancer Ther 2006; 5: 3294-3302. Buka okungaqondakali.
    192. UShivashankara, A. R., Azmidah, A., Haniadka, R., Rai, M. P., Arora, R., noBaliga, M. S. Ama-ejenti wezokudla ekuvimbeleni i-hepatotoxicty eyenziwe ngotshwala: ukubonwa kwangaphambi kokubanjwa. Umsebenzi Wokudla. 2012; 3: 101-109. Buka okungaqondakali.
    193. UPreuss, HG, Wallerstedt, D., Talpur, N., Tutuncuoglu, SO, Echard, B., Myers, A., Bui, M., noBagchi, D. Imiphumela ye-niacin-bound chromium ne-grape seed proanthocyanidin ekhishwe iphrofayili ye-lipid yezihloko ze-hypercholesterolemic: isifundo somshayeli. UJ Med 2000; 31 (5-6): 227-246. Buka okungaqondakali.
    194. U-Eyi, E. G., Engin-Ustun, Y., Kaba, M., noMollamahmutoglu, uL. Ankaferd wokumisa igazi ekulungiseni i-episiotomy. I-Clin Exp Obstet Gynecol 2013; 40: 141-143. Buka okungaqondakali.
    195. UGupta H, uPawar D, uRiva A, et al. Isivivinyo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa yi-placebo sokuhlola ukusebenza kahle nokubekezeleleka kwenhlanganisela eyenziwe kahle yezitshalo ekuphathweni kweziguli ezine-hypercholesterolemia eyinhloko kanye ne-dyslipidemia exubile. I-Phytother Res 2012; 26: 265-272. Buka okungaqondakali.
    196. UBarona J, u-Aristizabal JC, uBlesso CN, et al. Ama-polyphenols wamagilebhisi anciphisa umfutho wegazi futhi akhuphule i-vasodilation egeleza ngokugeleza emadodeni ane-metabolic syndrome. J Okunomsoco 2012; 142: 1626-32. Buka okungaqondakali.
    197. UMeng X, Maliakal P, Lu H, et al. Amazinga e-urinary ne-plasma we-resveratrol ne-quercetin kubantu, kumagundane, nakumagundane ngemuva kokungeniswa kwamakhompiyutha amsulwa nejusi lamagilebhisi. J Agric Ukudla Chem 2004; 52: 935-42. Buka okungaqondakali.
    198. UWard NC, uHodgson JM, uCroft KD, et al. Ukuhlanganiswa kwe-vitamin C ne-grape-seed polyphenols kwandisa umfutho wegazi: isilingo esilawulwa ngokungahleliwe, esingaboni kahle, esilawulwa yi-placebo. J Hypertens 2005; 23: 427-34 .. Buka okungaqondakali.
    199. I-Snow LA, i-Hovanec L, i-Brandt J. Isivivinyo esilawulwayo se-aromatherapy sokuyaluza ezigulini zasekhaya lasebekhulile ezinokuwohloka komqondo. J Altern Complement Med 2004; 10: 431-7. Buka okungaqondakali.
    200. UGreenblatt DJ, von Moltke LL, Perloff ES, et al. Ukusebenzisana kwe-flurbiprofen nejusi ye-cranberry, ijusi lamagilebhisi, itiye, ne-fluconazole: in vitro and clinical studies. I-Clin Pharmacol Ther 2006; 79: 125-33. Buka okungaqondakali.
    201. U-Agarwal C, uSharma Y, u-Agarwal R. Umphumela we-Anticarcinogenic wengxenyenamba ye-polyphenolic ehlukaniswe nembewu yamagilebhisi kumaseli we-prostate carcinoma DU145 amaseli: ukuguquguquka kokusayina kwe-mitogenic kanye nabalawuli bomjikelezo wamaseli nokufakwa kwe-G1 ukuboshwa kanye ne-apoptosis. UMol Carcinog 2000; 28: 129-38 .. Buka okungaqondakali.
    202. UPataki T, Bak I, Kovacs P, et al. Ama-proanthocyanidins wembewu yamagilebhisi athuthukise ukuvuselelwa kwenhliziyo ngesikhathi sokuphindwa kabusha ngemuva kwe-ischemia ezinhliziyweni zamagundane ezizimele. NginguJ J Clin Nutrit 2002; 75: 894-9.
    203. UBagchi D, uBagchi M, uSohoh SJ, et al. Ukuvikelwa kwamaselula ngama-proanthocyanidins atholakala embewini yamagilebhisi. U-Ann N Y Acad Sci 2002; 957: 260-70.
    204. UNuttall SL, uKendall MJ, uBombardelli E, uMorazzoni P. Ukuhlolwa komsebenzi we-antioxidant wokukhishwa kwembewu yamagilebhisi okulinganiselwe, iLeucoselect. UJ Clin Pharm Ther 1998; 23: 385-89. Buka okungaqondakali.
    205. UBernstein DI, uBernstein CK, uDeng C, et al. Ukuhlolwa kokusebenza kahle komtholampilo nokuphepha kokukhishwa okuhlanganisiwe ekwelapheni i-rhinitis yokugula okwenzeka ngezikhathi ezithile zonyaka: isifundo somshayeli. I-Ann Allergy Asthma Immunol 2002; 88: 272-8 .. Buka okungaqondakali.
    206. UStein JH, uKeevil JG, uWiebe DA, et al. Ijusi lamagilebhisi eliphuzi lithuthukisa ukusebenza kwe-endothelial futhi linciphisa ukutholakala kwe-cholesterol ye-LDL ku-oxidation ezigulini ezinesifo somthambo we-coronary. Ukusakazwa 1999; 100: 1050-5 .. Buka okungaqondakali.
    207. UFreedman JE, uParker C, uLi L, et al. Khetha ama-flavonoid nejusi lonke kusuka kumagilebhisi ansomi kuvimbela ukusebenza kweplatelet futhi uthuthukise ukukhishwa kwe-nitric oxide. Ukusakazwa 2001; 103: 2792-8 .. Buka okungaqondakali.
    208. UChisholm A, uMann J, uSkeaff M, et al. Ukudla okunothe ngama-walnuts kunomthelela omuhle kuphrofayili ye-plasma fatty kuzihloko ezisezingeni eliphakeme ze-hyperlipidaemic. I-Eur J Clin Nutr 1998; 52: 12-6. Buka okungaqondakali.
    209. Ikhodi ye-elekthronikhi yemithethonqubo kahulumeni. Isihloko 21. Ingxenye 182 - Izinto Ngokuvamile Zaziwa Njengokuphepha. Kutholakala ku: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
    210. I-Chevallier A. I-Encyclopedia Yezitshalo Zokwelapha. ILondon, e-UK: UDorling Kindersley, Ltd., 1996.
    211. Iqembu elisebenza ngeBIBRA. Ama-Anthocyanins. Iphrofayili yobuthi. IBRARA Toxicol Int 1991; 6.
    212. UVaswani SK, uHamilton RG, uCarey RN, et al. I-Anaphylaxis urticaria ephindaphindayo kanye ne-angioedema kusuka kumagilebhisi hypersensitivity. J Umzimba Wezokwelapha I-Immunol 1998; 101: S31.
    213. Peirce A. I-American Pharmaceutical Association Umhlahlandlela Osebenzayo Wemithi Yemvelo. ENew York, NY: UWilliam Morrow noCh., 1999.
    214. Anon. Ama-OPC (ama-Oligomeric Proanthocyanidins). Usokhemisi Wezemvelo 2000. http://www.tnp.com/substance.asp?ID=181. (Kufinyelelwe ku-3 Juni 2000).
    215. UMeyer AS, Yi OS, Pearson DA, et al. Ukuvinjelwa kwe-lipoprotein oxidation yabantu ephansi maqondana nokwakheka kwama-phenolic antioxidants kumagilebhisi (i-Vitis vinifera). J Agric Ukudla Chem 1997; 45: 1638-43.
    216. UPutter M, uGrotemeyer KH, uWurthwein G, et al. Ukuvinjelwa kokuhlanganiswa kweplatelet okubangelwa ukubhema yi-aspirin ne-pycnogenol. IThromb Res 1999; 95: 155-61. Buka okungaqondakali.
    217. UBombardelli E, Morazzoni P.Vitis vinifera L.Fitoterapia 1995; LXVI: 291-317.
    218. UXiao Dong S, uZhi Ping Z, uZhong Xiao W, et al. Ukuthuthuka okungenzeka kwe-metabolism yokuqala yokudlula ye-phenacetin ngokufaka ujusi wamagilebhisi ezifundweni zaseChina. UBr J Clin Pharmacol 1999; 48: 638-40. Buka okungaqondakali.
    219. UKiesewetter H, uKoscielny J, uKalus U, et al. Ukusebenza kokukhishwa ngomlomo kweqabunga elibomvu lomvini NJENGOBA 195 (folia vitis viniferae) ekungazini kahle okungamahlalakhona (izigaba I-II). Isilingo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa yi-placebo. I-Arzneimittelforschung 2000; 50: 109-17. Buka okungaqondakali.
    220. UCovington TR, et al. Incwajana Yezidakamizwa Ezingabhalisiwe. Umhla ka-11. IWashington, DC: I-American Pharmaceutical Association, 1996.
    221. ILeung AY, Foster S. Encyclopedia Yezithako Ezivamile Zemvelo Esetshenziswa Ekudleni, Izidakamizwa Nezimonyo. Okwesibili. ENew York, NY: UJohn Wiley & Sons, 1996.
    222. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
    Kugcine ukubuyekezwa - 06/03/2020

    Iseluleko Sethu

    Yini i-Ibogaine nemiphumela yayo
    Impilo

    Yini i-Ibogaine nemiphumela yayo

    I-Ibogaine iyi ithako e i ebenzayo e ikhona empandeni ye it halo a e-Afrika e ibizwa nge-Iboga, e inga et henzi wa ukukhipha ubuthi emzimbeni na engqondweni, i ize ekwelapheni uku et henzi wa kwezidak...
    Izinzuzo eziyi-9 zama-clove (nokuthi uzisebenzisa kanjani)
    Impilo

    Izinzuzo eziyi-9 zama-clove (nokuthi uzisebenzisa kanjani)

    I-clove noma i-clove, ebizwa ngokwe ayen i I yyomgium aromaticu , i enzo omuthi ilu izo ekulweni nobuhlungu, ukutheleleka, futhi futhi i iza ukukhuli a i ifi o obulili, futhi itholakala kalula ezitolo...